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PREFACE 
Cancer is the second largest cause of death 
with about one-quarter of the population in Western 
Society developing malignancies. Epidemiological 
studies of different populations and of migrants moving 
from one area to another suggest the important role of 
environmental factors in the causation of cancer. 
Prevention of cancer to a significant measure thus could 
be possible by the appropriate identification of the 
responsible chemical (Sobels, 1984). 
Eversince the industrial revolution which led 
to the modernization of the world, we are constantly 
being forced to breathe in the polluted air, to drink 
the contaminated water and to eat the adulterated food. 
Especially, in the last three decades, there has been an 
unparallel expansion in the chemical industry as 
witnessed by the development of many new organic 
chemical products and increased product applications 
(Ames, 1979). 
In view of the large number of compounds for 
screening, it is very difficult rather impossible, to 
thoroughly test the mutagenic and carcinogenic potential 
of biologically and industrially important compounds. 
Because of this as well as other reasons, short-term 
tests have been developed (Ames, 1971; Ashby and 
Tennant, 1988). 
(viii) 
Naturally occurring as well as synthetic 
steroids have been constantly used in various industries 
(Fishbein, 1984). Several steroids have been reported to 
be mutagenic and carcinogenic on the basis of short-term 
tests (Dunkel et al., 1985). Systematic and thorough 
screening of these chemicals especially those having 
some biological activities, therefore, seems to be 
desirable not only to understand their toxic behaviour 
but also for understanding their mechanism of carcinoge-
nesis. 
Certain derivatives of the steroids were synt-
hesized in the Chemistry Department of our University 
with the view to develop pharmaceutically important 
compounci having diversified type of biological activiti-
es. As we anticipate further developments in this area 
of pharmaceutical chemistry (Shafiullah et. aj^ . , 
1983,1988), these steroids were selected for the mutage-
nicity testing employing the Ames test as well as 
E.coli. lambda and Mud testing systems. In. vitro 
studies were also carried out to study the interaction 
of a highly mutagenic steroid I with DNA. Moreover, an 
attempt was also made towards the structural requirement 
for the mutagenicity of steroids to elucidate the 
mechanism of steroid action. 
In the first chapter of this thesis, review of 
literature is presented to become acquainted with the 
(ix) 
latest trends in the field of mutagenicity testing. 
The second chapter describes the general 
materials and methods like bacterial and phage strains, 
composition of media and buffers and list of steroids 
employed in these investigations. 
Third chapter incorporates the data on the 
Ames testing of steroids. 
Survival of SOS defective E.coli K-12 strains, 
as well as induction of X in its lysogen and p-
galactosidase in the Mud (Ap, lac) fusion strains have 
been presented in the fourth chapter. 
Fifth chapter deals with the studies on 
possible generation of active oxygen radical species by 
means of several scavengers and contribution of several 
substituted moieties/groups of the test steroids respon-
sible for the mutagenic activity. 
Sixth chapter embodies several in vitro techn-
iques to study the interaction of steroid with DNA. 
Seventh chapter is devoted for general 
discussion and conclusion drawn from the experimental 
data. In the last, bibliography and summary are documented. 
CHAPTER I ; REVIEW OP LITERATURE 
Cancer is derived from the Greek word 
*Karkinos' meaning crab. It is a condition resulting 
from the uncontrolled reproduction of cells. The cells 
in a cancer do not multiply at a faster rate than normal 
cells but they do multiply more frequently as the time 
between divisions diminishes. They escape controlling 
factors and eventually form a cluster of cells. Soon 
the cluster becomes an abnormal functionless mass of 
cells called a tumour. The body normally responds to a 
tumour by surrounding it with a capsule of connective 
tissue. Such a tumour is said to be benign. However, if 
the cells multiply too rapidly to be restricted or if 
they break out of the capsule and metastasize, the 
tumour is described as malignant. The condition is now 
called cancer, meaning that the cells are radiating out 
like the ^arms of a crab' (Alcamo, 1987). 
One of the most striking properties of the 
neoplastic state is its heritable nature. This is also 
true of the preneoplastic state. The heritable nature 
of both the preneoplastic and the neoplastic state has 
focussed speculation that the pathogenesis of cancer 
involves permanent alterations in gene expression 
perhaps accompanied by permanent alterations in gene 
structure, i.e. mutation (Friedberg, 1985a). These 
loosely knit concepts are embodied in the general theory 
of carcinogenesis called the ''somatic mutation' theory 
(Florey, 1962; Lloyd-Luke et al., 1978) which dates back 
to observations by Boveri (1914) of altered nuclear 
morphology in cancer cells. The somatic mutation theory 
may be stated as follows: Agents that initiate 
neoplastic transformation do so by interacting with the 
DNA of cells, causing damage. The results with the Ames 
test strongly support the somatic - cell mutation theory 
of cancer (Flessel et al., 1987). 
The oncogene theory which is also a well-
documented one, suggests that the genes to transform a 
cell, the oncogenes transform the normal cell to a 
cancer cell (Cooper, 1982; Fink, 1984). Genetic changes 
which contribute to cancer include altered gene 
function, altered expression of genes or their loss 
(Ponder, 1988). 
It has long been known that cancer can arise 
as a result of exposure to a variety of agents, and 
studies on the mechanism of the induction process have 
revealed that pure chemicals themselves are able to 
produce cancer (Miller, 1978). Damage to DNA by 
environmental mutagens may be the main cause of death 
and disability in advanced societies (Cairns, 1975). It 
is believed that this damage, accumulating during our 
lifetime initiates most human cancer and genetic defects 
and is quite likely a major contributor to aging 
(Burnet, 1974) and heart disease as well (Pearson et 
al., 1975). 
Since a large proportion of human cancer may 
arise from chemical causes, cancer prevention will 
depend to a large extent upon the recognition and 
possible elimination of environment and endogenous 
exposure to carcinogenic agents (Doll and Peto, 1981). 
Rapid and accurate, in vitro tests such as the 
Salmonella microsome test play a crucial role in the 
identification of environmental mutagens and minimizing 
human exposures (McCann and Ames, 197 6; Masayoshi, 
1988) . 
As some degree of exposure is unavoidable, 
particularly that arising from natural sources, 
effective prevention must also depend upon methods to 
prevent the development of neoplasia following exposure. 
Ultimately this may only be attainable through a 
thorough understanding of each sequential stage of the 
carcinogenic process (Saffhill et al., 1985). 
Carcinogenic Agents and their Mechanism of Action 
A high proportion of human cancers are attributed to 
environmental agents, mainly the chemicals. 
Epidemiological evidence strongly suggests that there is 
a major ^environmental' factor in the occurrence of 
cancer. This factor is a combination of all aspects of 
our life styles, including social and cultural habits, 
diet, agricultural practices and exposure to man-made 
pollutants. Many estimates of the proportions of 
cancers caused by specific environmental factors have 
been made (Farmer, 1982). 
It is frequently assumed that DNA damaging 
agents are carcinogenic because they induce mutations. 
However, another strong possibility is that the damage 
leads to heritable changes in the methylation of 
cytosine in DNA. Considerable evidence exists that gene 
expression in mammalian cells is in part controlled by 
methylation of specific DNA sequences (Robin, 1987). 
Carcinogens may act by altering the normal epigenetic 
controls of gene activity in specialized cells and 
thereby produce aberrant heritable phenotypes. It is 
known that agents which inhibit DNA methylation can be 
carcinogenic and that tumour cells are altered in DNA 
methylation (Robin, 1987). 
One of the theories of etiology of cancer, 
which is being widely accepted, holds that the major 
cause is damage to DNA by oxygen radicals and lipid 
peroxidation (Totter, 1980; Ames, 1983). There is an 
increasing amount of data which suggests that chemical 
carcinogens may cause both direct DNA damage, i.e., 
carcinogen-DNA adducts, and indirect DNA damage by 
causing formation of free radicals and superoxides that 
react with DNA and cause molecular lesions (Cerutti, 
1985; Michael et al., 1989). 
Most chemical carcinogens are alkylating or 
acylating agents (electrophilic reagents) or produce 
such compounds following metabolism in the body. This 
means that they have electron deficient center and will 
combine with electron-rich center within the cell. 
Reaction with DNA is the most important process in the 
initiation of mutagenesis and carcinogenesis, although 
reaction with certain amino-acids in proteins will also 
occur (Farmer, 1982). Alkylating agents are able to 
react at many sites in DNA, in particular at the ring 
nitrogen and the exocyclic oxygen atoms of the DNA bases 
and at the oxygen atoms of the phosphate internucleotide 
linkages (Margison and O'Connor, 1979; Singer and 
Kusmierek, 1982; Pegg, 1983). Substitution at the N-7 
position of guanine in DNA is usually the major reaction 
product with alkylating carcinogens although many other 
products such as 3-alkyladenine, 3-alkylguanine, 0^-
alkyl guanine, alkylthymidine, 3- alkylcytosine and the 
exocyclic N^ - alkylguanine are also formed (Farmer, 
1982). 
Majority of chemical carcinogens are known to 
form covalent adducts with DNA (Miller, 1978; O'Connor, 
1981) and there is now a large body of evidence 
implicating DNA as a critical target in chemically 
induced cancer. Studies with many alkylating agents 
have indicated that it is their capacity to react with 
certain oxygen-atoms in DNA, in particular those 
associated with promutagenicity, which provides an 
indication of their carcinogenic potential (Loveless, 
1969; Saffhill et al., 1985). 
Certain promoters of carcinogenesis act by 
generation of oxygen radicals, this being a common 
property of these substances. Many carcinogens which do 
not require the action of promoters and are by 
themselves able to induce carcinogenesis also produce 
oxygen radicals (Demopoulos et_ al.. , 1980) . The 
mechanism of action of promoters involves the 
expression of recessive genes and increase in gene copy 
number through chromosome breaks and creation of 
hemizygosity (Varshavsky, 1981; Kinsella, 1982). 
Promoters also cause modification of prostaglandins 
which are intimately involved in cell-division, 
differentiation and tumour growth (Fisher et al., 1982). 
Since virtually every chemical known to cause 
cancer in humans also causes cancer in animals (lARC 
Monographs, 1972-1975; Tomatis et al., 1973; Epstein, 
1974) the simplest assumption is that any chemical which 
is a carcinogen in an animal test is likely to be a 
human carcinogen, though, there are many uncertainities 
in determining the risk to humans from animal data 
(Epstein, 1974; Mantel and Schneiderman, 1975; Ames et 
al. . 1987). In general chemicals carcinogenic in one 
species are carcinogenic in other species (lARC Monogra-
phs, 1972-1975; Tomatis et al., 1973) although the 
carcinogenic potency of a particular chemical can vary 
considerably depending upon the animal species in which 
it is tested and the manner in which the chemical is 
administered (lARC Monographs, 1972-1975; Weisburger, 
1973, 1975; Sontag et al., 1975). Chemicals of very 
similar structure can also differ greatly in carcinogen-
ic potency (McCann et ai., 1975a). 
Correlation of Carcinogenesis and Mutagenesis 
Ames test has been widely used to investigate the 
mutagenic potential because many carcinogens are also 
mutagenic (Flessel et al. , 1987) although a high degree 
of variation was obtained with regard to the sensitivity 
of Ames test ranging from 45% to more than 90% (McCann 
et al., 1975b; Levin et al., 1984; Tennant et al., 1987; 
Zeiger et al., 1987). It was also suggested that a high 
level of sensitivity is often more a characteristic of 
the composition of the test material than that of the 
test system (McCann et al., 1975b). It is also notewor-
thy that as the time have elapsed from the first Ames 
test conducted by McCann et al (1975a) to correlate the 
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Fig.l. A hypothetical chemical showing main structural units 
( a - r ) which would lead to a chemical being classed 
as a potential carcinogen. The units ( a - r ) are 
the regions which would react with DNA based on identical 
or comparable carcinogen structures in animals. 
(Adopted from Ashby, J. and Tennant, R. (1988) Mutat. 
Res., 204, 17 - 115). 
mutagenic potential of a carcinogen upto the work of 
Tennant et al ^1987) there appears a continuous decrea-
se in the degree of sensitivity by Ames testing. Zeiger 
et al. (1987) reported that the Ames test has a sensitiv-
ity (percentage of carcinogens identified as mutagens) 
of only 54% and a specificity (percentage of non-carcin-
ogens identified as non-mutagens) of only 70%. Even 
worse, Tennant e£ al (1987) found that the Salmonella 
assay would only identify about 45% of carcinogens. 
These results are at variance with the observations made 
a decade ago when sensitivities and specificities of 90% 
or more were claimed for the Ames test (McCann et al., 
1975a; McCann and Ames, 1976). This looks disastrous 
for carcinogenicity screening that expensive animal 
carcinogenicity studies were the only way to identify 
carcinogens. But the new work of Ashby and Tennant 
(1988) (the same authorswho forced re-evaluation of the 
Ames test) lifts this gloom. From their comparison, 
Ashby and Tennant still conclude that there is about a 
90% correlation between structural analysis - looking at 
reactive sites on a chemical (Fig. 1) and Salmonella 
assay results for 115 carcinogens, 24 equivocal carcino-
gens and 83 non-carcinogens. Salmonella, they argue, is 
a sensitive method for picking out chemicals that are 
genotoxic and could attack DNA. 
Nestman (1986) stated that a mutagen is a 
mutagen, not necessarily a carcinogen. For instance 
10 
caramel, a sugar derivative which is widely used as a 
food colouring and flavouring agent, is also mutagenic 
in Salmonella test system, but has no carcinogenic 
effect when fed to rats as 6% of the diet for 2 years 
(Evan et al., 1977). Also, despite the evidence for a 
role of mutagenesis in carcinogenesis, certain chemicals 
have also been proposed as nonmutagenic carcinogens 
(Carl et al., 1988). 
Cancer and DNA Dgunaqe 
Damage to DNA is likely to be a major cause of cancer 
and other diseases (Hiatt et al., 1977; Ames, 1979). 
There is an evidence which support that carcinogens and 
radiations likely to initiate most human cancers and 
genetic defects do so by damage to DNA (McCann et al., 
1975a). Defined precisely DNA damage is an alteration 
that constitute a stumbling block for the replication 
machinery and hence hampers the replication of DNA, 
endangering the survival of the cell (Devoret, 1979). 
The correlation between radiation - induced 
damage and cancer has long been apparent to radiation 
biologists but through molecular evidence it has been 
found that DNA damage is a direct cause of cancer. The 
evidence comes from patients suffering from xeroderma 
picrmentosum (Devoret, 1979) . With certain eukaryotic 
11 
cells, the consequences of DNA damage can also be 
assessed by cytogenetic analysis. The human disorders 
ataxia telangiectasia. Bloom^s syndrome and Fanconi^s 
anemia are genetic diseases characterized by an increas-
ed susceptibility to cancer (Walker et al., 1985). 
Studies with Poecilia formosa showed an 
increased incidence of tumours in recipients bearing 
cells maintained under non-DNA repair conditions, 
thereby implicating DNA damage as a specific etiological 
factor in the neoplastic transformation (Hart and 
Setlow, 1975; Woodhead and Scully, 1977; Woodhead et 
al.. 1977). Study with Syrian hamster also suggested a 
causal relation between DNA damage and neoplasia 
(DiPaolo and Donovan, 1978; Doniger et al., 1981). 
DNA Repair 
DNA is the primary carrier of genetic information and 
the structural integrity of DNA is a prerequisite for 
gene expression (Modak, 1972) . It is a known fact that 
primary structure of DNA is dynamic and subject to a 
constant change (Friedberg, 1985b). Ionizing and UV-
radiations as well as multitude of other chemical agents 
upset the genetic and metabolic machinery of the living 
system. That would perhaps render our planet barren 
were it not subjected to the constant cellular 
monitoring and repair. Moreover, the contemporary 
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global environment also posed a continual threat to the 
heriditary material. The living systems have, 
therefore, evolved repair processes to maintain 
structural and functional fidelity of DNA against a 
large range of insult (Friedberg, 1985b). The molecular 
mechanisms involved in repair of damaged portions of DNA 
and their restriction into functionally intact 
informational units is fundamental to the maintenance of 
the genomic integrity (Modak, 1972). Defective DNA 
repair could cause an accumulation of lesions or 
mutations which might be either lethal, lead to an 
altered phenotype, or neoplastic transformation. Repair 
at the cellular and macromolecular level is multiple in 
its form and varies as a function of species, tissue and 
stage of the cell cycle (Hart et al., 1979). 
A great deal of research has been directed 
towards gaining new insights into the mechanistic 
regulation of repair machinery in Escherichia coli. The 
genetic studies have identified a large number of genes 
participating in the repair of damaged DNA (Walker, 
1985). 
The earliest suggestion on recovery of 
bacteria after exposure to ultraviolet (UV) light was 
made by Hollaender and Curtis in 1935. Later, Kelner 
(1949) observed that exposure of UV-irradiated bacteria 
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to visible light reversed the killing and mutagenic 
effect of UV light. He coined the term 
^photoreactivation'. The isolation of an E.coli by Hill 
(1958) provided the first evidence on genetic control of 
radiation sensitivity. Setlow and Carrier (1964) and 
Boyce and Howard - Flanders (1964) independently demons-
trated that UV-induced thymine dimers in bacterial DNA 
were not excised in a UV-sensitive strain but were 
excised in the wild-type strain. This suggested that 
excision of thymine dimers from bacterial DNA may be 
important for cell survival and that it is genetically 
controlled. 
Further, the same repair system has been shown 
to operate on the damage induced in DNA by carcinogens, 
mutagens and other hazardous chemicals (Ishi and Kondo, 
1975; Seeberg, 1981; Friedberg, 1985b). The foregoing 
developments paved the way for the systematic study of 
DNA repair mechanisms in prokaryotes and thus led to the 
discovery of additional repair systems. The following 
repair systems have been shown to be existing in 
bacteria: 
Photoreactivation; The simplest class of repair pathway 
is photoreactivation that directly rectifies the cyclob-
utane type pyrimidine dimers in UV-irradiated DNA 
without the formation of new phosphodiester bonds 
(Walker et al., 1985). This type of recovery process 
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requires the exposure of cell to visible light. It was 
the first system to be observed in vitro (Rupert et al., 
1958) and was the first to be characterized with regard 
to mechanism (Rupert, 1962a, b). Photoreactivation is a 
universal phenomenon because it is known to occur in E. 
coli. yeast and possibly in higher animals and plants 
(Schild et al., 1984). 
Excision Repair; An important mechanism for cell 
survival after UV-irradiation depends upon the release 
or excision of pyrimidine dimers from the DNA by 
excision enzymes, and the subsequent reconstruction of 
the twin helix by repair enzymes that make use of the 
intact opposite strand as template. Excision repair 
appears to be a significant source of DNA repair virtua-
lly in all organisms (Walker et al., 1985). Mechanism 
of repair of DNA by excision has been studied extensive-
ly using mutants of E.coli sensitive to ultraviolet 
radiations (Setlow and Carrier, 1964; Howard-Flanders et 
al., 1966) . This repair system have at least four 
steps viz. incision, excision, gap filling and sealing 
(Hanawalt et al., 1979; Walker, 1985). 
Post- Replication Recombinational Repair; The DNA 
lesions, especially UV-induced pyrimidine dimers that 
are neither split photoenzymatically nor removed from 
DNA by excision repair, block the continuous progress of 
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the DNA replication fork. However, they do not prevent 
the reinitiation of DNA synthesis at a point beyond the 
dimer (Rupp and Howard-Flanders, 1968). As a result, 
gaps are produced in the daughter strand opposite the 
lesions. The continuity of daughter strand is 
interrupted by gaps, of about 1000 nucleotides (Howard-
Flanders, 1968; Benbow et al., 1974). This type of 
enzymatic DNA repair by which the molecular weight of 
the newly synthesized strand increases is called post 
replication repair. This was first demonstrated in 
E.coli by Rupp and Howard-Flanders (1968). 
Inducible Error-prone SOS Repair; The term *SOS' 
(international distress signal) implies to an error 
prone repair, induced under enormously stressed 
condition of growth as a last resort for the survival of 
cells. The existence of *SOS' network was clearly 
postulated by Defais et ai (1971) and was further 
developed and amplified by Radman (1974, 1975) and 
Witkin (1976). The exposure of E.coli to the agents 
that damage DNA or interfere with DNA replication 
results in the induction of a diverse set of 
physiological responses called ^SOS' response. It 
requires recA"*" and lexA"*" genotypes of host (Miura and 
Tomizawa, 1968; Defais et al., 1971). ^SOS' repair is a 
highly integrated and sophisticated regulatory network 
that require de novo protein synthesis for expression 
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(Koval, 1986). It is an inducible repair process and is 
believed to be responsible for a common mutagenic 
pathways (Radman, 1974; Witkin, 1976; Walker, 1985; 
Strauss, 1989) . In response to DNA damages calling for 
the SOS repair, DNA repair systems in E.coli are 
activated, cell division is altered, integrated viruses 
are induced and respiration is blocked (Witkin, 1976; 
Little and Mount, 1982). 
Several bacterial genes have been identified 
which coordinately function in *SOS' repair. These are 
uvrA and uvrB (DNA repair) , umuC (mutagenesis) , sfiA 
(filamentation), himA (site-specific recombination) and 
several din genes with unknown functions in addition to 
the recA and lexA genes (Witkin, 1976; Kenyon, 1983) . 
Role of recBC and recN genes has also been suggested in 
*SOS' induction (Chaudhury and Smith, 1985; Finch et 
al., 1985). 
RecA and lexA genes are the regulators which 
control ^SOS' response. Under normal conditions lexA 
protein represses the subordinate genes of the system 
and recA protein derepresses these loci in response to 
DNA damage (Kenyon, 1983). LexA is a self repressor and 
also binds to similar operator sequences in each gene 
(Little et ai. , 1981; Sancar et al. , 1982; Little, 
1984). During ^SOS' induction, the lexA repressor is 
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cleaved between ala-gly bond by the second regulator, 
the recA protein (Little, 1984). RecA protein acquires 
a specific protease activity to form recA when it 
interacts with an intracellular molecule that results 
from certain type of DNA damage and therefore, recA 
protein is considered to play a key role in the 
induction of ^SOS' response (Radman, 1975; Takahashi et 
al., 1986). 
The ^SOS' response is transient and thus 
following DNA repair and removal of inducing stimulus(i) 
recA protein loses its protease activity, (ii) level of 
lexA repressor rises, and (iii) repression of the SOS 
genes resumes (Brent and Ptashna, 1981; Sancar et al.. 
1982) . 
The accumulation of certain deoxyribonucleo-
tide monophosphates and a high level induction of recA 
gene expression have been suggested to stimulate the 
*SOS' repair (Gottesman, 1981). Moreover, Salles et al 
(1983) reported the full amplification of recA protein 
without any amplification of other single strand binding 
proteins under ^SOS' inducing conditions. Bebenek and 
Janion (1985) proposed the possible role of mismatch 
repair also in the induction of ^SOS' response. 
Mutagenesis resulting from ^SOS' processing of 
damaged DNA template is targeted and is not due to the 
induction of some random mutator activity (Miller, 1983; 
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Walker, 1984). Radman (1974, 1975) suggested that the 
appearance of mutation during ^SOS' processing might be 
due to the inducible infidelity of DNA replication, 
because pyrimidine dimers were found to block the chain 
elongation by purified DNA polymerase I and III on UV-
irradiated DNA template. Subsequent studies revealed 
the involvement of inducible inhibition of proof reading 
(3' -> 5' exonuclease) activity of DNA polymerases 
(Radman et al., 1977; Villani et al., 1978). Moreover, 
the lexA dependent conversion involving the 6 subunit of 
DNA polymerase III holoenzyme to ^SOS' polymerase has 
also been postulated (Scheuermann et. ai., 1983; 
Piechocki et al., 1986). Lu et al (1986), in fact, have 
demonstrated the recA mediated inhibition of 3' -> 5' 
nuclease activity of isolated 6 subunit of DNA 
polymerase III and was suggested to be responsible for 
targeted mutagenesis. 
Mutagenicity and carcinogenicity Testing Systems 
It has become increasingly apparent that the traditional 
methods for identifying carcinogens by using long-term 
studies in rodents are unable to meet demands for a 
quick, sure and inexpensive identification of 
environmental carcinogens. This has brought about an 
intensive search for appropriate test systems and over 
the last few decades a series of short-term tests have 
been published (Dyrby and Ingvardsen, 1983). 
19 
Long-term tests, howsoever are expensive and 
time consuming they have given considerable evidence in 
estimating the potency of a carcinogen (Farmer, 1982). 
But, there is a problem of predicting whether humans 
will respond to the carcinogen in the same way as 
animals (Farmer, 1982). There are several instances 
in which only one species like mouse was found to 
respond to the test and the rat was ineffective. Then 
how can we extrapolate the risk from rodents to humans, 
a very dissimilar long-lived species. Opposite was also 
found in which a chemical was found to be carcinogenic 
by epidemiological studies but was non-carcinogenic in 
rodents (Ames et al., 1987). 
Short-term tests (STTs) for genotoxic 
chemicals were originally developed to study mechanisms 
of chemically induced DNA damage and to assess the 
potential genetic hazard of chemicals to humans. The 
four better known short-term tests are chromosome 
aberration, sister chromatid exchange, mutagenicity 
assay using mouse lymphoma cells and the Ames test 
(Ashby and Tennant, 1988). 
The chromosome aberrations are the result of 
effects that occur anywhere in the genome therefore, 
because of the difference in size between a genome and a 
gene, the cytogenetic effects manifested as gross 
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chromosome aberration occur at a much greater frequency 
than do mutations observed at a single locus. This test 
has provided a very sensitive method for determining, 
whether or not environmental agent can interact with the 
genetic material (Wolff, 1984). 
For the majority of chemical mutagens which 
are S- dependent agents the sister chromatid exchange 
(SCE) has proved to be even more sensitive than the 
induction of aberrations. The SCEs, like chromosome 
aberrations induced by S-dependent agents, are formed by 
unrepaired lesions that are present when the cell passes 
through S phase and the chromosome replicate. SCE 
method has been used as a test system to tell whether or 
not a chemical is potentially dangerous and to determine 
which of the metabolites of a premutagenic and 
precarcinogenic agent might be the likely ones to 
interact with DNA and cause its effect (Wolff, 1984; 
Renata et al., 1989). They observed that no combination 
of the four STTs is any better than Salmonella on its 
own for flagging probable carcinogens. The role of 
these tests has increased however because of 
accumulating evidence in support of the somatic mutation 
theory of carcinogens (Straus, 1981; Crawford, 1985; 
Ames et ai., 1987) and because of reports that many 
rodent carcinogens in vitro are genotoxic in short-term 
tests (Ames, 1979) . The in vitro STTs have the 
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advantage that they can be conducted relatively quickly 
and inexpensively compared to long-term carcinogenicity 
assays with rodents and do not involve testing in 
animals. Early studies of concordance between results 
from in vitro STTs and rodent carcinogenicity tests were 
highly encouraging (Durston et al., 1973; Sugimura et 
al., 1976; Devoret, 1979). 
Wide use of short-term tests for detecting 
mutagens (Ames, 1979) and a number of animal cancer 
tests on plant substances have contributed to the 
identification of many natural mutagens and carcinogens 
in the human diet (Kapadia, 1982). There is a range of 
applications in which STTs have been used successfully, 
from the identification of mutagenic fractions in 
complex mixtures such as cooked meat (Hatch et al.. 
1984; Sugimura, 1985) or air pollutants (Schuetzle and 
Lewtas, 1986) to the early identification of genetic 
toxicity in the development of new chemical products 
(Tassignon, 1985). 
On the basis of a literature-derived study of 
the performance of STTs (Waters and Auletta, 1981), it 
became apparent that there were two impediments to a 
thorough evaluation of the ability of these tests to 
predict rodent carcinogenicity; for most STTs there was 
a dearth of results for documented noncarcinogens 
(Shelby and Stasiewiez, 1984; Kier et aJ., 1986; Ray et 
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al., 1987) and too few chemicals had been tested in 
multiple STTs to predict carcinogens. Even with a 
battery of assays, not all rodent carcinogens are in 
vitro mutagens nor are all in vitro mutagens rodent 
carcinogens. STTs do, however, contribute to offer an 
economical, rapid and dependable means to detect 
genotoxic chemicals (Tennant et al., 1987). 
Mud-and Induct Testing system 
One of the most powerful tools developed for use in 
genetic studies of E.coli and related bacteria is the 
operon fusion vector, Mu cts (Ap^.lac) (Casadaban and 
Cohen, 1979) referred to as Mud (Ap,lac). The so-called 
^Mud-test' has been used to generate the Mud (Ap,lac) 
fusions to genes involved in the expression of p-
galactosidase (Kenyon and Walker, 1980), mutagenesis 
(Bagg et al., 1981), DNA repair (Kenyon and Walker, 
1981) and methionine biosynthesis (Mulligan et. aj^ . , 
1982). Similar test, also called ^Chromotest' is used 
to identify the mutagens and carcinogens as well as used 
to screen the agents for their antimutagenic activity 
(Dzhezhelava et al., 1989) The ^Inductest' using lambda 
lysogen alone have also been used to detect the 
mutagenic activity of chemicals (Moreau et al., 1976). 
The ^Inductest, Mudtest and Chromotest' are 
the different parameters to estimate the extent of DNA 
damage to determine the mutagenic potential of a 
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chemical based on the expression of SOS-genes in treated 
E.coli cells (Moreau et al., 1976; Bagg et al., 1981; 
Kenyon and Walker, 1981). 
Ames Testing System 
Among the various bacterial manifestations of DNA 
damage, Ames chose mutagenesis as the basis of his 
pioneering work to develop a test for potential 
carcinogens (Devoret, 1979). The Salmonella-
mutagenicity test (Ames et al., 1975), along with other 
short-term assays (Hollstein et al., 1979), is being 
extensively used to survey a variety of substances in 
our environment for mutagenic activities (Ames, 1984). 
The test measures back mutation in several specially 
constructed mutants of Salmonella. 
The test has been adopted for use in detecting 
chemicals which are potential human carcinogens or 
mutagens by adding homogenates of rat liver (or other 
mainmalian tissue) directly to the petri plates as an 
approximation of mammalian metabolism into the in vitro 
test (Ames et ai., 1973b) . This test is also 
instrumental in understanding the primary events of the 
carcinogenic process initiated by chemicals (Devoret, 
1979). The compounds are tested on petri-plates with 
several specially constructed mutants of Salmonella 
tvphimurium LT2 type selected for sensitivity and 
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specificity in being reverted from a histidine 
requirement back to prototrophy by a wide variety of 
mutagens (Ames et al., 1973b). 
Several histidine - requiring mutants in the 
standard set of Salmonella tester strains have GC base 
pairs at the critical site for reversion e.g. -C-C-C- in 
the base-pair substitution strain, TAIOO (Barnes et ai-, 
1982) , -c-C-C-C-C-C- in the frameshift tester strain, 
TA97a (Levin et al., 1982b) and -C-G-C-G-C-G-C-G- in the 
frameshift tester strain, TA98(Isono and Yourno, 1974). 
However, TA102 and TA104 have AT base pairs at the 
critical site for reversion. TA102 and TA104 strains 
detect a variety of oxidants and other agents as 
mutagens which were not detected in the standard tester 
strains (Levin et aJ., 1984; DeFlora et ai., 1989). 
Steroids; Uses and Applications 
Naturally occurring as well as synthetic steroids have 
been commonly used in various industries (Fishbein, 
1984) . Several steroids have been reported to possess 
anti-inflammatory (Boltralik, 1988; Henry et al., 1989), 
anesthetic (Evelyne et al., 1988), anabolic (Fennessey 
et, aj^ . , 1988), angiostatic (Larrian, 1989), anti-
angiogenic (Roger et al., 1988; Judah et al-/ 1989), 
cardioactive (Karel and Thomas, 1987) and antidiabetic 
(Ryoji et al., 1988) activities. 
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Certain steroids have also been reported to 
control energy metabolism throughout pregnancy (Baird et 
al., 1985). Steroid-alkaloid formulations have been used 
for skin disorder treatment (Chain et al., 1984). Also, 
there are some steroidal compounds which increase 
resistance against drugs and toxic agents (Kourounakis, 
1986) . It has been found that medroxy progesterone 
acetate inhibits growth of hormone - dependent mammary 
carcinoma cells (Costa et al., 1986). Fluorouracil-
estradiol conjugate (Asano et al., 1978) and modified 
steroid - alkylating agents) (Panayotis et al., 1983) as 
well as gestagens (Nishida et ai. , 1986) have been 
reported to possess antitumour and antimutator 
activities respectively. 
Steroids As Potential Carcinogens 
There is a high risk of development of cancer with the 
use of steroids. Several steroids have been reported to 
possess tumourigenic and carcinogenic activities 
(Allen etal., 1981; Kay, 1981; Candrian, 1984). 
Several steroids have been reported to be 
mutagenic and carcinogenic on the basis of short-term 
tests (Dunkel et al., 1985). Various steroids have been 
shown to play an active role in human carcinogenesis 
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(Lipsett, 1986). Especially the steroidal hormones and 
their derivatives have been demonstrated to be mutagenic 
and carcinogenic in the bacterial as well as in the 
animal testing systems (Kay, 1981; McKillop et ai., 
1983; Metzler, 1984). 
Estrogenic hormones have been shown to possess 
the tumourigenic activity and are assumed to serve as 
regulators of tumour growth. These hormones probably 
maintain the neoplastic state of the cells in a variety 
of well characterized experimental animal tumour systems 
(Katzenellenbogen, 1986). Growth promoting effect on 
hepatocarcinoma has also been demonstrated to be 
mediated by estrogen-receptor in the male rats 
(Kohigashi e£ al.., 1986) . Carcinomas in ovary tumours 
are more often estrogen positive than benign tumours 
(Lantta and Acta, 1984). 
The mechanism of action of steroid hormones 
involves their interaction with tissue - specific 
binding sites and results in a precise modulation of 
gene expression by regulating some RNA processing 
events. It has been found that the majority of the 
human primary breast tumours contained detectable levels 
of steroids in the homogenate or cytosol fractions 
(Prakash et ai., 1986). Tissue steroids have been found 
to play a role in regulating aromatase activities in 
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breast and endometrial cancer (James et al., 1986). 
Steroid alcohol sulfotransferases have been isolated 
from the cytosol of a human breast carcinoma cell line 
MCF-7 (Rozhim et ai. , 1986). Moreover the 
stereochemical complementarity of DNA and reproductive 
steroid hormones have been found to correlate with 
biological activity (Lawrence et al., 1986). 
Contraceptive steroids have been assessed for 
toxicological and carcinogenic hazards (Heywood, 1986). 
Oral contraceptives are believed to pose a high 
carcinogenic risk with regards to the mammary and 
reproductive glands (Heywood, 1986). They have also 
been shown to enhance liver tumour in the Egyptian toad 
(Sadek and Abdelmeguid, 1986). Moreover, contraceptive 
steroids have been shown to enhance mutagenic activity 
in Salmonella (Rao et al., 1983) and were also found to 
be the promoter of tumourous growth in rat liver (Heike 
et al., 1986; Reinhard et al., 1989). 
Recent Advances in Carcinogenicity 
Testing Systems 
Ashby and Tennant (1988) concluded from their survey of 
around 222 carcinogens and non-carcinogens that the 
Salmonella assay (the so-called Ames test) does not 
identify all carcinogens. It does work for certain 
chemicals particularly those that become reactive 
electrophiles and attach to DNA (Miller and Miller, 
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1977) , but it certainly does not work for all of them 
(Tennant, 1987). Moreover, Tennant (1987) observed that 
three of the better known short-term tests: (the 
chromosome aberrations, sister chromatid exchange and 
mutagenicity assay using mouse lymphoma cells) would 
falsely label more non-carcinogens as carcinogens owing 
to their high sensitivity and less specificity than the 
Ames test. He further observed that no combination of 
the four tests is any better than Salmonella on its own 
for flagging probable carcinogens. A second genotoxic 
assay conducted jji vivo was suggested by Ashby and 
Tennant (1988). The test is the mouse micronucleus 
assay which works on cells with chemically induced 
chromosome aberrations having an unusual distribution of 
chromatin during cell division which can be observed as 
distinct micronuclei in cytoplasm. Validation of this 
genotoxicity assay, is likely to be of more use than in 
vitro tests which do not aid identification of 
carcinogens. 
The reliable and sensitive detection of 
characteristic molecular markers for human exposure to 
chemical carcinogens is no longer barrier to further 
study, as several sophisticated analytical techniques 
such as tandem mass spectrometry and fluorescence line-
width narrowing spectrophotometry are now available 
(Shuller, 1987). 
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A new precipitation assay used together with 
the alkaline unwinding assay provides a rapid means of 
detecting DNA damage in addition to strand breaks based 
on the relative amount of damage measured by the two 
assays (Peggy et ai., 1988). 
A new Salmonella mutagenicity test method is 
under development to test a chemical with more than one 
strain simultaneously (the "SIMULTEST") that is, 
different Salmonella typhimurium tester strains with R-
plasmid and without plasmid are used in combination on 
the same plate. This approach may be useful in reducing 
the workload associated with mutagenicity testing with 
Salmonella (Nestman et ai., 1987). 
The process of chemical carcinogenesis is well 
understood to support a policy distinction between 
genotoxic and nongenotoxic carcinogens. Conservative 
Mathematical model could account for the possibility 
that a carcinogenic chemical would "add on" to the 
background of cancer (Perera, 1988). 
The Salmonella TA1535/psk 1002 strain is used 
to detect environmental mutagens in which the expression 
of the umuC gene for p-D- galactosidase is used as a 
parameter. The sensitivity of detecting this enzyme in 
this method is amplified by 10-1000 fold by a 
chemiluminescence spectrometry method (Masayoshi, 1988). 
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Ames et al (1987) have invited a great deal of 
controversy over the popular view that synthetic 
carcinogens are posing a higher risk than the natural 
ones. According to that review carcinogenic hazards 
from current levels of pesticide residues or water 
pollution are likely to be of minimal concern relative 
to the background level of natural substances. However 
the authors have put a question mark on the degree of 
importance on the natural exposures. 
Animal models provide invaluable information 
in studies of carcinogenesis (Harris, 1985; Hay, 1988). 
Extrapolation of this information from experimental 
animals to humans remains however, a problematic 
endeavour. Most scientists consider the qualitative 
extrapolation to be accurate, i.e., a chemical that is 
carcinogenic in experimental animals is likely to be 
carcinogenic in humans. Although there is a positive 
association between adduct levels and tumour-initiating 
potency in many but not all studies using animal models 
(Wogen and Gorlick, 1985) it is not known whether such 
association exists in human carcinogenesis (Harris, 
1985). Lifetime carcinogenicity studies will still be 
needed for those nongenotoxic carcinogens that are 
tissue, sex, species specific in contrast to the 
genotoxic carcinogens that cause tumours in different 
species at multiple sites. The latter will need only a 
limited bioassay (Hay, 1988). 
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Definition of the Problem and Objectives 
of the Ph.D. Work 
Dithiolanes have potential applications in pharmacology 
(Taninaka, 1979; Crump, 1980; Wieland et al., 1980; 
Robbe et al., 1982; Jinnian et al., 1989). More specif-
ically steroidal dithioketals may have a future role in 
cancer chemotherapy (Blickenstaff and Foster, 1961). 
Some steroidal sulfones possess antitubercular (Merchant 
et al., 1982), antitumour (Moreau et al., 1979), anti-
inflammatory (Verma, 1981) and herbicidal (Louis, 1978) 
activities. Homo-aza-steroidal esters are known for 
their antineoplastic activity (Pairas et al., 1986). 
Moreover, some oxazoles and their derivatives have been 
reported to possess anti-inflammatory, analgesic, 
antibacterial, antimicrobial and antiviral (Turchi and 
Dewar, 1975) activities. As pharmaceuticals, oxazoline 
are useful as antihypertensive as well as central 
nervous system regulators (Levitt, 1970 a,b). 
Both the synthetic steroids and aziridines 
have also been shown to possess diversified types of 
biological activities including their contraceptive, 
antitumour, antineoplastic, cytotoxic and antibacterial 
characters (LaBrecque, 1961; Knipling, 1962; Borkovec 
and Woods, 1963; Oboshi et ai., 1967; Derner and Hans, 
1969 ; Zbigniew and Krystyma, 1988; Henry et al., 1989; 
Nakaaki, 1989). As we expect further developments in 
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this area of pharmaceutical chemistry, we made use of a 
local collection of such steroids (Shafiullah ^ ai- ; 
1983,1988,1990) for mutagenicity testing. The practical 
application of this work is to highlight putative 
hazards in the light of the genotoxicity of certain 
other steroids (Allen et ai. , 1981; Metzler, 1984; 
Heywood, 1986; Sadek and Abdelmeguid, 1986). The short-
term assay would obviously be the first step forward in 
the direction of minimizing the exposure to the potenti-
ally toxic steroids, as prevention is always better than 
cure. Moreover, the rigidity of the cholestane steroid 
used in these studies allows structure - function 
analysis of mutagenic functional groups without the 
complications of conformational variation of straight 
chain compounds. The work presented in the thesis 
covers ^ a preliminary study on the mutagenic activity of 
steroids and their mechanism of action in the biological 
systems. 
In view of the available literature, we 
initiated the work on the screening of some dithiolane, 
sulfone, oxathiolane and aziridinyl steroids for 
mutagenicity and carcinogenicity employing several 
mutagenicity testing systems. The major objectives were 
as follows: 
i) Screening of available steroids for 
mutagenicity by means of Ames testing system 
(Spot-test). 
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ii) Quantitative screening of test steroids to 
construct the complete dose-response curves. 
iii) Mutagenicity testing of the potent compounds 
employing the E.coli. lambda as well as the Mud 
systems. 
iv) Studies on the nature of potentially mutagenic 
lesion in DNA produced by the potent test 
steroid employing (i) hydroxyapatite chromatog-
raphy (ii) S^ nuclease hydrolysiss(iii) melting 
profile and (iv) alkaline unwinding. 
V) Quantitative determination of the modified 
bases in the presence of the test steroid 
employing DEAE-Sephadex A50 column chromatogra-
phy. 
vi) Studies on the role of several light and heavy 
chemical moieties and of different positions of 
the parent nuclei to ascertain the contribution 
towards the mutagenic potential of the 
compound. 
vii) Studies on the role of oxygen radical species 
in the mutagenic activity of the test steroids. 
CHAPTER II : GENERAL MATERIALS AND METHODS 
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TABLE 1. The Salmonella tvphimurium and Escherichia coll 
strains used in this study have been tabulated as under: 
Strain 
designation 
Relevant genetic markers Source 
TA97a 
TA98 
TAIOO 
TA102 
TA104 
AB1157 
AB2463 
AB2494 
C600 
HB101/ACI857 
lysogen 
Ames Strains 
uvrg, hisD6610f bio, £fa, 
R-factor plasmid-pKMlOl 
uvrB. hisD3052f bio, rfa, 
R-factor plasmid-pKMlOl 
uvrB. hisG46f bio, rfa. 
R-factor plasmid-pKMlOl 
rfa .R-factor plasmid-pKMlOl. 
multicopy plasmid-pAQl 
containing hisG428 
auxotrophic marker and 
tet^ 
uvrB. hisG428f yfa, 
R-factor plasmid-pKMlOl 
E.ooli K-12 strains 
thirl, gyqE3, tnr-l, leyp^, 
EE2M, hisG4, lacYl. F", £^^, A^ 
recAlS. thi-lr arqE3. thr-1. 
leuB6, proA2, hisG4, F", Str^,A^ 
lexA. t h i - 1 . t h r - 1 . leuB6. 
proA2. hisG4, metB. l acYl . 
F~, S t r S A ^ 
thr. leu, thi, lac, A^ 
E£o, ieu, thi, 
lac,ACI857 immunity coded by 
cl gene 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Ames, B.N. 
Howard-
Flanders, P. 
Howard-
Flanders, P. 
Howard-
Flanders, P. 
Thomas, R. 
Srivastava, 
B.S. 
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TABLE 2. The Characteristics of Mud Strains and Phage 
used in this study: 
E.coli 
Strain/ 
phage 
Relevant genetic 
markers 
Source 
MALI03 
MAL315 
(Mud I) 
(Mud II) 
F , Mu C ts62, MudI, 
(lacIPOZYA, qpt. arq F, pro 
AB)XIII, str, Ap^ 
M8820RM3 with Mud II 
(and an uncharacterized 
auxotroph) 
Mu c ts62 dIl(Tn3'(Ap^,tnp 
R'): Bam HI: lacAYZ-W209-trp 
^ABC) (transcription fusion 
phage) 
Mu C ts62 dll 301 (Tn3'(Ap 
tnpR'): BamHI: lacAYZ':Bam 
HI: Mu right-end 116 bp) 
(translation fusion phage) 
R 
Parish, J.H. 
Parish, J.H. 
•Genetic markers are described in Casadaban and Chou 
(1984). All strains are E.coli K-12. 
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Methods 
Maintenance and growth of bacteria; Each strain of 
Salmonella typhimuriuin was streaked over master plate. 
A single colony was picked up, grown in minimal medium 
and repurified by streaking over fresh master plate. 
Likewise each strain of E.coli and a lysogen was 
streaked over nutrient agar plates. A single colony was 
picked up and repurified by streaking over agar plates. 
The culture was tested on the basis of associated 
genetic markers raising it from a single colony from the 
master plate. Having satisfied with the test clone the 
culture was raised and streaked over minimal and 
nutrient agar slants. It was then allowed to grow 0/N 
at 37°C and stored at 4°C. Every month cultures were 
transferred over fresh slants with TA102 strain as an 
exception. It was transferred after every 15 days. 
Stabs were prepared for longer storage. 
Overnight culture of S.typhimurium strains 
were used as such for experiments. Overnight culture of 
E.coli and lysogen were raised in nutrient broth at 37'C 
and 32°C respectively. The culture was diluted fifty 
times in fresh broth follov/ed by shaking at 37 °C and 
32 °C till the cell density reached to about 2x10^ 
viable counts ml"-'-. Such exponential cultures were used 
in all the experiments. 
Materials 
Media for Ames Strains 
Medium for master plates and slants: The composition 
of the medium for Ames tester strains to prepare master 
plates and slants is as under; 
Sterile 50 x VB Salts* 20 ml 
Sterile agar 15 g / 910 ml 
Sterile 40% glucose 50 ml 
Sterile histidine. HCI.H2O 10 ml 
(2 g per 400 ml H2O) 
Sterile 0.5 mM biotin 6 ml 
Sterile ampicillin solution 3.15 ml 
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(8 mg/inl 0.02 N NaOH) _ ^^ 
Sterile tetracycline solution 
(8 mg/ml 0.02 N HCl) 
For the preparation of plates, the above 
components were mixed with the molten agar. 
• •Tetracycline was added only for use with TA102 which 
is tetracycline resistant. 
•Stock solution of VB salts (IX) was prepared using the 
following ingredients: 
MgS04.7H20 0.2 g/1 
citric acid monohydrate 2.0 g/1 
K2HPO4 (anhydrous) 10.0 g/1 
NaHNH4P04.4H20 3.4 g/1 
The salts were added in the order indicated to 
warm distilled water and each salt was allowed to 
dissolve completely before adding the next. The 
solution was then autoclaved for 20 min at 121°C. 
Minimal glucose plates for mutaqenioitv assay; 
Sterile VB salts 20 ml 
Sterile 40% glucose 50 ml 
Sterile agar 15 g/930 ml 
distilled water 
The above components were mixed with the 
molten agar and then 30 ml was poured over each plate. 
Top agar for mutagenicity assay; The top agar contain-
ed 0.6% agar powder and 0.5% NaCl. 10 ml of sterile 
solution of 0.5mM histidine. HCl/0.5mM biotin was added 
to the molten agar and mixed thoroughly by swirling. 
0.5 mM histidine/biotin solution for mutagenicity assay; 
D-Biotin 30.9 mg 
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L-Histidine. HCl 24.0 mg 
Distilled water 250.0 ml 
First biotin was dissolved by heating the 
water to the boiling point. Then histidine was mixed to 
it and finally the solution was sterilized for 20 min at 
121°C. 
0.2M Sodium Phosphate buffer. pH 7.4; 
NaH2P04.H20 13.8g/500 ml 
Na2HP04 14.2g/500 ml 
The pH was adjusted to 7.4 and sterilized at 
12l''C for 20 min. 
Sg mix for mutagenicity assay: 
So (livers of Sprague-Dawley rats, Aroclor 
1254-induced) mix was prepared by mixing (per 3.0 ml): 
sterile distilled water, 1.185 ml; 0.2M NADP, 0.120 ml; 
IM glucose-6-phosphate, 0.015ml; sterile 0.4M MgCl,-
1.65M KCl salts, 0.060 ml; Rat liver Sg fraction, 0.120 
ml ( 4% ) . Sg mix was freshly prepared for each 
experiment. 
Oxvaen-radical scavengers used for mutagenicity assay: 
Stock solutions of superoxide-dismutase (1 mg/ml), 
catalase (16 mg/ml), formate (10 mM) , mannitol (10 mM) 
and thiourea (lOmM) were prepared in sterile distilled 
water. 
Media for E.coli K-12 strains and lysogen 
Nutrient broth (13q/l); Nutrient broth obtained from 
Hi-media (India) had the following composition: 
Peptone 5.0 g/1 
NaCl 5.0 g/1 
Beef extract 1.5 g/1 
Yeast extract 1.5 g/1 
pH(approx.) 7.4±0.2 
In the nutrient broth obtained from Difco 
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(U.S.A.)/ NaCl was also added to it 
Nutrient broth 8 g/1 
NaCl 5 g/1 
Nutrient agar (Hard agar); 
Nutrient broth 13 g/1 
Agar powder 15 g/1 
Soft agar; The composition of soft agar used for 
lysogen work was as under: 
Nutrient broth 13 g/1 
Agar powder 7 g/1 
Maso^.7HgO Solution (O.OIM); For all dilutions, 0.01 M 
MgSO^ solution was used. 
Preparation of Mud (Ap. lac) phage lysates; Mud (Ap, 
lag) lysates were prepared by heat induction of Mall03 
and Mal315, a bacterial strain that has both the Mud 
(Ap, lac) bacteriophage and a Mu c ts helper phage 
inserted in its chromosome. 
A 5.0 ml L-broth culture of Mall03 and Mai 
315, inoculated from a fresh 0/N culture was grown in a 
flask at 30°C with vigorous shaking (approximately 2 h). 
At a density of 2-3x10 cells ml"^, the culture was 
shifted to a 43°C bath for 25 min. Rapid shaking during 
phage growth was important to ensure sufficient 
aeration. The flask was then transferred to a 37°C 
shaking bath and was incubated until the cells had lysed 
and the culture became clear (20 - 60 min) . After the 
addition of a few drops of chloroform, the culture was 
left at room temperature for 5-10 min. Further 
operations were conducted at 4°C. A 0.05 ml aliquot of 
0.2M lead acetate was added and the culture was then 
centrifuged twice to pellet the debris. The supernatant 
was stored at 4°C over a few drops of chloroform. 
The lysates were usually prepared fresh since 
the titre of Mud (Ap, lac) tends to drop fairly rapidly 
with time. Care in removing the cellular debris 
increased the stability of the lysate. 
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Media for Mud strains 
LB/Ca"*"^  broth; The broth contains a final concentration 
of 2.5 mM CaCl2 added after autoclaving. 
Mg Minimal Medium; 
A. Na2HP04.7H20 
KH0PO4 
2, 
0. 
1 . 
0. 
1 9 2 , 
0, 
0, 
0, 
0, 
0, 
.2 
,8 
,0 
.2 
.0 
,2 
.4 
.8 
.8 
. 8 
g 
g 
g 
g 
ml 
ml 
ml 
ml 
ml 
ml 
NaCl 
NH4CI 
Distilled H2O 
B. MgS04 
(0.01 M) 
C. Maltose 
(2.0%) 
D. Leucine 
(10 mg/ml) 
E. Threonine 
(10 mg/ml) 
F. Thiamine 
(10 mg/ml) 
The solutions (A-F) were sterilized separately 
and added afterwards in the order indicated. 
For the preparation of Mg minimal plates, agar 
and salts were made two fold concentrated and mixed 
after sterilization. When desired, p-galactosidase indi-
cator, 5-bromo-4-chloro-3-indolyl p-D-galactopyranoside 
(X-gal) dissolved in N,N'-dimethylformamide was added 
after autoclaving to a final concentration of 40 ug/ml. 
Z-buffer for the assay of p-aalactosidase; 
Na2HP04.7H20 0.60 M 
NaH2P04.H20 0.40 M 
KCl 0.01 M 
MgS04.7H20 0.001 M 
p-mercaptoethanol 0.05 M 
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pH was adjusted to 7.0 
(This buffer was not autoclaved). 
Buffers and Solutions for In Vitro tests 
0.0IM TNE buffer; For preparing DNA solution 2 mg/ml 
solution of calf-thymus DNA was prepared in O.OIM TNE or 
TN (0.01 M Tris-HCl, pH 7.5; 0.01 M NaCl and 10"'* M 
EDTA) buffer. 
IM Sodium phosphate buffer (pH 7.0); IM sodium 
phosphate buffer was prepared for hydroxyapatite chroma-
tography. Further dilutions of the buffer were done 
with this stock buffer. 
Solutions for Sj^  nuclease hydrolysis 
S-L nuclease dilution (1 unit/xil) : 
Sterilized S^ nuclease buffer 200 ul 
(pH 4.5) 
Sterilized glycerol (5%) 50 ul 
Sterilized distilled water 744 ul 
S-^ nuclease 6 ul 
( = 1000 units) 
S-j^  nuclease buffer (pH 4.5^ 
0.5 M Sodium acetate (pH 4.5) 
1.0 mM ZnSO^ 
Perchloric acid was 14% and bovine serum albumin 10 
mg/ml in sterilized distilled water. 
Diphenylamine reacrent for the estimation of DNA; 
Diphenylamine 250 mg 
CH3COOH (glacial) 25 ml 
H2SO4 (cone.) 675 jal 
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Steroids 
All the test steroids were dissolved in 30 - 40% acetone 
plus 70 - 60% dimethyl sulfoxide mixture. Both the 
solvents used are the recommended solvents (Maron gt 
aJL. , 1981) . Since not much is known about the stability 
of steroids in solution, the doses were prepared 
immediately before use. 
The methods of the individual experiments are 
described in their respective chapter. 
Chemicals 
The following chemicals were used: 
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Chemicals Source 
Acetone 
Actinomycin D 
Agar powder 
Agarose 
Ammonium chloride 
Ampicillin 
3,4- Benzo^a' pyrene 
Biotin 
Bovine serum albumin 
5-Bromo-4-chloro-3-indolyl-p-D-
galactopyranoside 
Calcium chloride 
Calf thymus DNA (Type I) 
Catalase 
Chloroform 
Citric acid monohydrate 
Cobalt chloride 
Copper sulphate 
DEAE-Sephadex A-50 
Dimethyl sulphoxide 
B.D.H., India 
Sigma, U.S.A. 
Hi-media, India 
Gift from Dr.Shahid 
Jameel 
B.D.H., India 
Ranbaxy, India 
Koch-Light Ltd., 
England 
Nutritional Bio-
chemical Corpora-
tion, U.S.A. 
S igma, U.S.A. 
Gift from 
Dr.J.H. Parish, 
Univ.of Leeds,U.K. 
Sarabhai, M. 
Chemicals, India 
Sigma, U.S.A. 
Sigma, U.S.A. 
B.D.H., India 
B.D.H., India 
B.D.H., India 
E. Merck, India 
Sigma, U.S.A. 
B.D.H., India 
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Chemicals 
Diphenylamine 
Dipotassium hydrogen 
phosphate (dibasic) 
Disodium hydrogen phosphate 
Ethylene diamine tetraacetic 
acid 
Ferric chloride 
Ferrous sulphate 
Formaldehyde 
Formamide 
Glycerol 
D-Glucose 
Histidine monohydrochloride 
Hydrochloric acid 
Hydroxyapat ite 
Lead Acetate 
Leucine 
Magnesium sulfate 
Maltose 
Manganese chloride 
Mannitol 
p-Mercaptoethanol 
N,N'-dimethyl formamide 
Source 
Glaxo, India 
B.D.H., India 
Sarabhai, M. 
Chemicals, India 
s.d.Fine.Chem., 
India. 
Loba, Chem..India 
Sarabhai, M. 
Chemicals,India 
B.D.H., India 
E.Merck,India 
E.Merck,India 
B.D.H., India 
E.Merck,Germany 
B.D.H., India 
Sigma, U.S.A. 
B.D.H., India 
E.Merck,Germany 
E.Merck,India 
Difco, U.S.A. 
E.Merck, India 
Difco, U.S.A. 
E.Merck,Germany 
Sarabhai,M.Chemicals 
India 
Nickel sulphate B.D.H., India 
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Chemicals Source 
Sigma, U.S.A. 
Hi-media,India 
Hi-media,India; 
Difco, U.S.A. 
E.Merck,India 
B.D.H., India 
s.d.Fine.Chera. 
India 
Sigma, U.S.A. 
Gift from 
Dr.J.H.Parish 
B.D.H. Anala R 
India 
E.Merck,Germany 
Glaxo, India 
Sarabhai, M. 
Chemicals,India 
B.D.H., India 
Loba, India 
B.D.H., India 
B.D.H., India 
Sigma, U.S.A. 
IDPL, India 
Huffman-La Roche & 
Co.Ltd.,Switzerland 
Nicotinamide dinucleotide 
phosphate 
Nutrient agar 
Nutrient broth 
Perchloric acid 
Potassium chloride 
Potassium dihydrogen phosphate 
S^ nuclease 
Sg Fraction 
Sodium acetate 
Sodium ammonium phosphate 
Sodium carbonate 
Sodium chloride 
Sodium dihydrogen phosphate 
Sodium dodecyl sulfate 
Sodium formate 
Sodium hydroxide 
Superoxide dismutase 
Tetracycline 
Thiamine 
Thiourea E.Merck, India 
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Chemicals 
Threonine 
Toluene 
Trichloroacetic acid 
Tris HCl 
Urea 
Zinc sulphate 
Source 
CSIR Center for 
Biochem. Delhi 
B.D.H., India 
CDH, India 
Sigma, U.S.A. 
E.Merck, India 
E.Merck, India 
Note: The chemicals which have not been included in this 
list were of analytical grade. 
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TABLE 3. The steroids/moieties used under study: 
S.No. Steroid Sym- M.P. 
bol ("C) 
Structure Relationship 
1. 3p-Acetoxy-5 ««-
cholestano[5,6-b] 
N-phthalimidoaz-
iridine 
2. Acetyl choleste-
rol 
.8 17 Potential 
moiety of 
steroid I 
3. Cholest-5-ene lb 
CgH^ 7 
-do-
4. N-amino-phth-
alamide 
Ic 200° 
to 
205° 
-do-
(Continued) 
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S.No. Steroid Sym- M.P. 
bol (°C) 
Structure Relationship 
5. 3p-ehloro-5 * -
cholestano[5,6-b] 
N-phthalimidoaz-
iridine 
II 156' 
6. 3^-Bromo-6,6-
ethylene dithio-
5 ec -cholestane 
I I I 140 C8Hi7 P a r e n t 
7 . 3 p - B r o m o - 6 , 6 -
ethylene •< - s u l -
fonyl-p-sulf inyl-
5 oc -cholestane 
IV 225' C9H17 Derivative 
0=S^02 
8. 3p-Bromo-6,6-
ethylene-disul-
fonyl-5 oC -
cholestane 
V 8H17 Derivative 
(Continued) 
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S.No, Steroid Sym- M.P. 
bol (°C) 
Structure Relationship 
3^-Chloro-6,6-
ethylene-dithio-
5 K-cholestane 
VI 143 gHi7 Parent 
10.3p-Chloro-6,6-
ethylene- ec-sul-
finyl-p-thio 5 «<:-
cholestane 
VII 145 :8Hl7 Derivative 
11.3p-Iodo-6,6-ethy- VIII 
l ene-d i th io -5 ec -
cholestane 
C8H17 Parent 
12.33-Iodo-6,6-ethy-
lene- ©c-sulfinyl-
p- th io-5 oc -
cholestane 
98^^17 
Derivative 
(Continued) 
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S.No. S t e r o i d Sym- M.P. S t r u c t u r e 
b o l ("C) 
R e l a t i o n s h i p 
1 3 . 3 p - I o d o - 6 , 6 - e t h y -
l e n e - o c - s u l f o n y l -
p - t h i o - 5 QC -
c h o l e s t a n e 
8Hl7 Derivative 
14. 3p-Acetoxy-5 oc 
cholestano[6oC, 
5-d]-l',3'-oxa-
thiolane-2'-
thione 
- XI 181' C8H17 
15. 3p-Chloro-5 oC -
cholestano[6oc, 
5-d]-l',3'-oxa-
thiolane-2'-
thione 
XII 163 C8Hl7 
16. 5 oC-Choles tano X I I I 87 ' 
[ 6 o C ; 5 - d ] - l ' 3 ' - t o 
o x a t h i o l a n e - 2 ' - 88 ' 
t h i o n e 
Ce^i? 
CHAPTER III : AMES TESTING OP STEROIDS 
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Introduction 
There is considerable evidence that a large proportion 
of human cancer may be caused by exposure to toxic 
chemicals in the environment, very few of which have 
been tested for carcinogenicity or mutagenicity. A 
programme of cancer prevention aimed at identifying and 
eliminating human exposure to hazardous chemicals 
requires the development of rapid, inexpensive and 
efficient short-term tests, to pinpoint dangerous 
chemicals among the thousands to which humans are 
exposed. The Salmonella/microsome mutagenicity test 
(Ames, 1971; McCann et aJ., 1975b) has been sufficiently 
developed and validated to be seriously considered for 
wide-spread use in this way. Considerable evidence 
accumulated so far indicates that with few exceptions 
carcinogens are mutagens (Ames et ai., 1973a,b; Flessel 
et al. , 1987) . It thus supports the desirability of 
using this type of rapid and economical test system as a 
screening technique (Ames, 1971; Ames et ai., 1973a,b). 
The work embodied in this chapter was, 
therefore, designed to screen the available cholesterol 
derivatives of steroids for their potential mutagenic 
and carcinogenic behaviour employing Ames-testing 
system. 
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Materials and Methods 
Bacteria, steroids and media are listed in Chapter II. 
All the media were freshly prepared. Two tests were 
routinely performed for testing the mutagenicity of the 
steroids according to the method of Maron and Ames 
(1983): spot test and plate incorporation assay. The 
cells were treated for 20 minutes following the preincu-
bation procedure in case of plate incorporation assay. 
For the metabolic activation of comparatively more 
potent steroids, 20 jul of Sg liver homogenate mix per 
plate was added. 
Spot Test; This test is the simplest way to test 
compounds for mutagenicity and is useful for the initial 
rapid screening of large number of compounds. This is a 
variation of the plate incorporation test in which the 
test chemical (steroid) was applied directly onto the 
surface of the minimal agar plate after it had been 
seeded with the bacterial tester strain. Appropriate 
concentrations of the steroids were added to the agar 
surface. 
A positive result in the spot test was 
generally not considered to be an adequate evidence for 
mutagenicity. Mutagenicity was therefore confirmed by 
quantitative plate incorporation test. 
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Plate Incorporation Assay: To 0.5 ml phosphate buffer, 
pH 7.5 (or 20 jul Sg mix) in sterile capped tube placed 
in an ice bath, appropriate concentration of the steroid 
and 0.1 ml fresh 0/N culture of the tester strain were 
added and incubated for 2 0 - 3 0 min at 37°C. Then 3.0 
ml molten top agar (held at 45"C) supplemented with 0.5 
mM His/Bio solution was added to each of the tubes 
containing treated culture. The contents were mixed and 
immediately poured over minimal glucose agar plate with 
swirling action to achieve uniform distribution of the 
top agar and allowed to harden on a level surface. 
Plates were inverted and placed in a dark, vented 
incubator maintained at 37°C for 48h. Revertant colonies 
were counted and mutation frequency was calculated by 
subtracting the spontaneous mutation from induced 
mutation. 
Solvent as control was also run 
simultaneously. 
Results 
Spot Test of Steroids;- Table 1 depicts the characteris-
tic reversion patterns of the standard strains in the 
presence of some test steroids. In view of the qualita-
tive assessment of the sensitivity of the tester 
strains, the number of revertants scored per spot for 
TA104 was found to be maximum. All the steroids that 
were tested exhibited a significant amount of mutagenic 
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activity in the tester strains but steroids I, II, V, 
VII and IX induced relatively greater number of reverta-
nts compared with other steroids. 
Plate Incorporation Assay (Dose-response relationship):-
Steroid I induced Reversion of Tester Strains; Fig. lA 
shows the number of histidine revertants upon treatment 
of the Ames strains with steroid I in the absence of Sg 
fraction. The steroid exhibited a significant level of 
mutagenicity with TA104 and TA102 strains even as small 
dose as 0.5 »g/plate but beyond 4 xig/plate the reversion 
property showed a sharp decline. The tester strains 
TAIOO, TA97a and TA98 also responded significantly to 
the test steroid but to a lesser extent. These strains 
could be listed in order of their steroid-induced 
mutagenesis as follows: 
TA104 > TA102 > TAIOO > TA97a > TA98 
The mutagenic activity remarkably enhanced in 
the presence of Sg mix (Fig. IB). Table 2 shows the same 
results as in Fig.l but in terms of ± standard 
deviation, p value and slope. 
Steroid II Induced Reversion of Tester Strains: The 
reversion of tester strains with steroid II at various 
doses in the absence of Sg is shown in Fig.2. It was 
observed that this steroid was weakly mutagenic on 
tester strains TA97a, TA98 and TAIOO but exhibited a 
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significant level of activity on TA102 and TA104 
strains. Strain TA104 displayed a sharp decline beyond 
the dose of 13 wg/plate but rest of the strains 
exhibited almost linear response beyond the dose of 0.5 
and 1.0 Aig/plate. 
The tester strains could be listed in order of 
their steroid-induced mutagenesis as follows: 
TA104 > TA102 > TAIOO > TA98 > TA97a 
Reversion of Ames Tester Strains in the Presence of 
Parent steroids III, VI and VIIIt The reversion of 
various Ames tester strains by the steroids in the 
absence of Sg fraction is shown in Fig.3. The steroids 
displayed the maximum mutagenic activity with strains 
TA102 and TA104. The TA97a tester strain, on the other 
hand did not respond at all with any of the parent 
steroids. The steroids exhibited mutagenicity at lower 
doses but became lethal after attaining a peak value. 
The order of sensitivity of the strains towards the 
steroids were as follows: 
III : TA104>TA102>TA100>TA98>TA97a 
VI : TA102>TA10^>TA100>TA98>TA97a 
VIII: TA10^ >TA10;2>TA100>TA 98 >TA97a 
Structurewise, the mutagenicity exhibited by 
the parent steroids were: 
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VI > III > VIII 
Steroid IV Induced Reversion of Tester Strains; The 
results in Fig. 4 show that the steroid exhibited a 
higher reversion activity on strains TA102 and TA104 
compared with other tester strains. The number of 
revertants scored per plate for TAI04 strain was found 
to be the maximum. Strains TA97a, TA98 and TAIOO 
showed a weak response compared with TA102 and TA104. 
However, the steroid demonstrated almost a linear dose -
response at levels that were not excessively toxic to 
any of the tester strains. Moreover, this steroid was 
found to be more mutagenic than its parent steroid III 
(Fig. 3). 
The order of sensitivity of the steroids with 
the tester strains was as follows: 
TAlO^ i > TA102 > TAIOO > TA97a > TA98 
Steroid V Induced Reversion of Tester Strains; Fig. 5A 
depicts the reversion pattern of tester strains at 
various concentrations of the steroid treatment in the 
absence of Sg fraction. The steroid showed a 
significant level of mutagenicity with TA104 strain at 
very low dose (0.5 jug/plate) but beyond 10 Aig/plate, the 
reversion property showed a sharp decline. It also 
induced a positive response with TA102 strain in being 
reverted at 0.5 ug/plate dose but showed a sharp decline 
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beyond the dose of 15 wg/plate. This steroid also 
displayed a linear dose-response at levels that were not 
excessively toxic to strains TA97a, TA98 and TAIOO. 
Moreover, this steroid exhibited significantly higher 
mutagenic activity than its parent (III) as well as 
another derivative (IV). These strains could be listed 
in order of their steroid-induced mutagenesis as 
follows: 
TA104 > TA102 > TA97a > TA98 > TAIOO 
Metabolic activation markedly enhanced the 
activity of this steroid (Fig. 5B). 
Reversion of Tester Strains in the Presence of Steroid 
VII; The reversion of tester strains with steroid at 
various doses in the absence of Sg fraction is shown in 
Fig. 6A. It was observed that this steroid was weakly 
mutagenic on tester strains TA97a, TA98 and TAIOO but 
exhibited strong activity on TA104 and TA102 strains. 
Strain TA104 reverted many times more compared with 
other tester strains. The dose beyond 15 jug/plate was 
found to be harmful for strains TA98, TAIOO and TA104, 
whereas with TA102, the number of revertants scored per 
plate was found to decline beyond 10 jag/plate. Moreover 
it showed greater mutagenic activity than its parent 
steroid (VI). The order of sensitivity of steroid with 
tester strains was as follows; 
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TA104 > TA102 > TAIOO > TA98 > TA97a 
The mutagenic activity was again markedly 
enhanced in the presence of Sg mixture as is shown in 
Fig. 6B. 
Steroid IX Induced Reversion of Tester strains: The 
reversion of tester strains with steroid in the absence 
of Sg fraction is depicted in Fig. 7A. Here, again 
TA104 was found to be the most responsive strain. The 
number of revertants per plate at the concentration of 5 
Mg was found to be the highest but showed a decline 
beyond this dose. This steroid was weakly mutagenic in 
the tester strains TA98, TA97a and TAIOO. The number of 
revertants per plate in strains TA102 and TAIOO declined 
beyond the dose of 7 jug, whereas in strain TA98 was 0.5 
iig. This steroid also was more mutagenic compared with 
its parent steroid (VIII). The order of sensitivity of 
the tester strains with this steroid was as follows: 
TA104 > TA102 > TA 97 > TA 100 > TA98 
The mutagenic activity further enhanced in the 
presence of liver microsomal fraction (Fig. 7B). 
Reversion of Tester Strains in the Presence of Steroid X: 
Fig. 8A shows the reversion pattern of tester strains in 
the presence of steroid X in the absence of Sg fraction. 
Strains TA102 and TA104 were found to be reverted more 
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efficiently compared with TA97a, TA98 and TAIOO. The 
reversion property for TA97a and TA102 declined beyond 
the dose of 10 xig/plate whereas for TA98, TAIOO and 
TA104, it declined beyond the dose of 15 Aig/plate. This 
steroid did not exhibit mutagenic activity with TA97a at 
the dose of 1 jag/plate. The steroid exhibited greater 
mutagenic activity compared with its parent steroid 
(VIII). 
The tester strains could be listed in order of 
their responsiveness with the steroid as follows: 
TA102 > TA104 > TAIOO > TA97a > TA98 
The mutagenic activity further enhanced in the 
presence of liver microsomal fraction (Fig. 8B). 
Reversion of Tester Strains in the Presence of Steroids 
XI, XII and XIII; The reversion of tester strains by 
the steroids in the absence of liver microsomal fraction 
is shown in Fig.9. The steroids displayed the maximum 
mutagenic activity with TA104 and TA102 strains. The 
tester strain, TA97a did not respond at all with XI and 
XII steroids but TAIOO responded weakly with these two 
steroids. The steroids exhibited mutagenicity at lower 
doses but became lethal after attaining a peak value. 
The strains could be listed in order of their 
sensitivity with steroids as follows: 
XI and XII : TA104 > TA102 > TAIOO > TA97a 
XIII: TA104 > TA102 > TAIOO > TA97a 
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Structurewise, the mutagenicity exhibited by 
the steroids was : 
XI = XII < XIII 
Comparison of Mutagenicity of steroids; A Summary chart 
Serieswise, the mutagenicity exhibited by 
steroids was as follows (compiled from the data 
presented in Table 3): 
1. Aziridine steroids 
2. Bromine substituted 
series 
3. Chlorine substituted 
series 
4. Iodine substituted 
series 
5. Oxathiolane series 
I > 
Acetoxy 
V > 
deriv. 
VII > 
deriv. 
IX > 
deriv. 
II 
Chlorine 
IV > III 
deriv. parent 
VI 
parent 
X > VIII 
deriv. parent 
XIII > XII = XI 
The overall sensitivity of steroids towards 
tester strains in general was : 
TA104 > TA102 > TAIOO > TA98 > TA97a. 
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Discussion 
The Salmonella test was first validated in a study of 
300 chemicals most of which were known carcinogens 
(McCann et al., 1975a; McCann and Ames, 1976, 1977). It 
was subsequently employed in other studies by the 
Imperial Chemical Industries (Purchase et al., 1976), 
and the International Agency for Research on Cancer 
(Bartsch et al., 1980). Nearly 90% of the carcinogens 
tested were found to be mutagenic in these studies, but 
there was considerable overlapping of chemicals tested. 
It is customary to define the compound as 
negative if none of the tester strains responds with and 
without metabolic activation upto the limit of toxicity, 
not exceeding to 5 mg/plate concentration (deSerres and 
Ashby, 1981; Dyrby and Ingvardsen, 1983). An increase 
in the number of colonies (over the number of spontaneo-
us background revertants) indicates that the chemical is 
mutagenic while the number of revertant colonies 
provides an index of the mutagenic activity of the 
sample (deSerres and Ashby, 1981; Levin et al., 1984; 
Flessel et al., 1987). 
Our results indicate an increase in number of 
revertant colonies with all the test steroids. 
Moreover, all the steroids exhibited a remarkable degree 
of mutagenicity with TA104 and TA102 strains (Tables 1 
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and 2; Figs. 1-9). It is also noteworthy that even in 
the absence of Sg microsomal fraction, usually all the 
tester strains responded significantly but the addition 
of microsomal fraction further enhanced the mutagenic 
activity of the steroids (Figs. 1,5,6,7 and 8 (B)). The 
enhanced activity of the steroids in the presence of Sg 
fraction suggests that the metabolic intermediate of the 
test steroids were also mutagenic. 
Table 4 shows the relevant genetic and 
biochemical markers of the Ames tester strains. The 
Salmonella strains lack error-prone repair (Walker, 
198^) due to the absence of a functional umuD gene 
(Herrera et al.., 1988) . The error-prone repair in Salmo-
nella is regained in the presence of pKMlOl which 
contains analogues of umuCD genes making the error-prone 
repair functional. Strain TA97a has been recommended for 
detecting frameshift mutagens (Levin et. aj^. , 1982a) 
whereas TA102 strain is known to detect the oxidative 
mutagens (Levin et ai., 1984). TA97a, TA98 and TAIOO 
tester strains contain G-C base pairs at the critical 
site for reversion (Isono and Yourno, 1974; Barnes et 
al., 1982; Levin et al., 1982a). With regard to the 
individual difference among the aforementioned G-C 
specific mutants, the first two strains are the 
frameshift type while TAIOO is the base-pair substituti-
on mutant (Isono and Yourno, 1974; Barnes et al., 1982). 
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The tester strains TA102 and TA104 are the transition 
mutants and contain A-T base pairs at the critical site 
for reversion (Levin et ^., 1982a) . In view of our 
findings, it is noteworthy that the test steroids prefe-
rentially act on the A-T base pair inducing a transition 
mutation in the DNA of tester strains (Tables 1 and 2; 
Figs. 1-9). 
Comparison of closely related structures 
permits identification of a number of features essential 
for the mutagenic activity. Among the acetoxy- and 
chloro- substituted aziridinyl steroids (I and II) which 
differ only at position 3 (Table 3 of Chapter II) the 
acetoxy - substituted steroid was found to be relatively 
more mutagenic compared with the chlorine - substituted 
one (Table 3; Figs.l and 2). This may be due to the 
bulky nature of acetoxy group and cleavage from the 
steroidal nucleus in the form of acetoxyl radical is 
more likely which can further interact with any reactive 
species in the system to form "OH radical and hydrogen 
peroxide. 
Among the halogen substituted steroids which 
differ only at position 3 (Table 3 of Chapter II) , the 
chloro-parent was found to be relatively more mutagenic 
compared with other two parent steroids. The parent 
compounds of chloro,- bromo- and iodo-substituted 
steroids (III, VI and VIII) contain the reactive thio 
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(-S-CH2-CH2-S-) moiety which was chemically converted into 
-OS-CH2-CH2-SO2-, -O2S-CH2-CH2- SO2-, -S-CH2-CH2-SO- and 
-S-CH2-CH2-SO2- in the derivatives (steroids IV, V, VII, 
IX and X; Table 3 of Chapter II) . A strong mutagenic 
activity was observed with the derivatives compared with 
their parent compounds (Table 3; Figs. 4,5,6,7 and 8). 
This indicates that probably oxygen atoms present in the 
dithiolanes were responsible for the enhanced mutagenic-
ity of the steroids. Moreover, as the number of oxygen 
atoms were increased, the extent of mutagenicity was 
also increased to a large extent (Figs. 4,5,6,7 and 8). 
It was found that the bromo-derivative which contained 
-O2S-CH2-CH2-SO2- group at the 6th position of the 
steroidal nucleus was the most mutagenic (Fig. 5). 
Among the oxathiolanes (XI, XII and XIII) 
the steroid which contained no bulky group at the 3rd 
position was comparatively more mutagenic compared with 
steroids XI and XII (Fig.9). 
The test steroids, especially those having 
aziridinyl, sulfonyl/sulfinyl moieties seem to have 
initiated the SOS - response with the concomitant 
induction of A.T->G.C transition mutation. 
According to Tennant et al (1987) only those 
compounds containing the electrophiles would be detected 
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as mutagens by the Salmonella test. This electron-
deficient region either already exists in these 
steroids, or seems to have been generated as a result of 
metabolic activation. In our test system the electroph-
ilic group or another reactive species appears to 
generate oxygen radical species (further extension of 
this work is described in Chapter V). There is at least 
one precedent for such a possible mechanism. Nakayama 
et ai (1983) showed that free radical reactions might 
account for the carcinogenicity/ mutagenicity of 
naphthylamine and amino azo dyes. With regard to the 
mutagenic potency of the test steroids, both the 
criteria seem to have been fulfilled as were laid down 
by Ames and Whitfield (1966), Ames et al (1972) and 
Creech et al (1972) . The compound should have a ring 
system capable of stacking interaction with DNA as well 
as should also contain an electrophilic group that can 
react with it. 
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TABLE 1. Ames Spot test of the Steroids 
s. 
No 
Steroids 
1. I 
2. II 
3. Ill 
4. IV 
5. V 
6. VI 
7. VII 
8. VIII 
9. IX 
10. X 
Amount 
spotted 
{*ig) 
5 - 1 5 
-do-
-do-
-do-
-do-
-do-
-do-
-do-
-do-
-do-
TA97a 
+ 
+ 
+ 
N.D 
+ 
+ 
+ 
+ 
± 
+ 
TA98 
+ 
+ 
N.D 
+ 
+ 
N.D 
+ 
N.D 
+ 
+ 
Strains 
TAIOO TA102 
± ± 
± ± 
++ 
N.D ± 
± 
± ± 
+ + 
+ + 
+ 
+ 
TA104 
+ 
+ 
-
++ 
++ 
-
++ 
+ 
-
+ 
Symbols for the number of revertants/spot (Spontaneous 
revertants subtracted): 
- = < control ; ± = < 10 - 30; + = 31 - 50; ++= 51 -
120; N.D= not done , * 
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F i g . 1. Dose - r e s p o n s e e f f e c t s of S t e r o i d I w i t h 
Ames t e s t e r s t r a i n s . S p o n t a n e o u s 
r e v e r t a n t s have been s u b t r a c t e d . A, -Sg,* 
B, +Sg 
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Fig, Dose - response effects of Steroid II 
with Ames tester strains. Spontaneous 
revertants have been subtracted. 
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Fig. 3 Dose- response effects of parent steroids 
with Ames tester strains. Spontaneous 
revertants have been subtracted. 
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Fig. 4. Dose-response effects of Steroid IV with 
Ames tester strains. spontaneous 
revertants have been subtracted. 
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Fig, Dose-response ef fec ts of Steroid V with Ames t e s t e r s t r a i n s . Spontaneous 
rever tan t s have been subtrac ted . A, -Sg,* 
B, +S Og . 
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F i g . 6, D o s e - r e s p o n s e e f f e c t s of S t e r o i d VI I w i t h 
Ames t e s t e r s t r a i n s . S p o n t a n e o u s 
r e v e r t a n t s have been s u b t r a c t e d . A, -Sg,* 
B, +Sg. 
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F i g . 7 Dose-response ef fec ts of Steroid IX with 
Ames t e s t e r s t r a i n s . Spontaneous 
rever tan t s have been subtrac ted . A, -Sg,* 
B, +S9. 
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Fig . 8 Dose-response e f f e c t s of S t e r o i d X with 
Ames t e s t e r s t r a i n s . Spon t aneous 
r e v e r t a n t s have been s u b t r a c t e d . A, -Sg; 
B, +Sg. 
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Fig. Dose-response ef fec ts of Steroid XI, XII 
and XIII with Ames t e s t e r s t r a i n s . 
Spontaneous r e v e r t a n t s have been 
subtracted. 
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TABLE 3. Comparison of Mutagenicity of Test Steroids 
(Summary) 
S. 
No 
Steroids Structural 
difference 
Dose of 
steroid 
ing/ ) 
plate) 
TA97a 
Strains 
TA98 TAIOO TA102 TA104 
Aziridine 
Steroids 
I 
II 
H3C-C-0- gp 
at 3rd posi-
tion of the 
steroidal 
nucleus 
Cl-gp at 3rd 
position 
153 
28 
195 
39 
244 
89 
394 
90 
757 
70 
Bromine 
substitut-
ed series 
III 
(parent) 
V 
(deriva-
tive) 
•S~CHo —CHo ~S" 
Dithio-gp at 
6th position 
10 
IV 
fderiva- |-OS-CH2-CH2-S02 
tive) 
oC- Sulfonyl 
p-sulfinyl 
at 6th 
position 
10 
O2S-CH2-CH2-SO2 
Disulfonyl 
gp at 6th 
position 
10 
0 
41 
68 
26 
26 
41 
47 
138 
11 
20 
222 
349 
30 
177 
981 
*r A«c No. '^  
!^^ T.- 7 /, ^ . ^ 
^:^fy 
Continued 
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S. 
No 
Steroids Structural 
difference 
Dose of 
steroid 
(jLig/pute) 
TA97a TA98 
Strains 
TAIOO TA102 
Chlorine-
substitu-
ted 
steroids 
VI 
(parent) 
V I I (deriva-
tive) 
•S~CH2'~CH2~S" 
Dithio gp at 
6th position 
S-CH2-CH2-SO 
oC-Sulfinyl 
p-thio gp at 
6th position 
10 
10 37 
39 
66 
86 
60 
62 
326 
10 
Iodine-
substitu-
ted series 
VIII 
(parent) 
IX 
(deriva-
tive) 
X 
(deriva-
tive) 
"S-CHo—CHo—S — 
Dithio gp at 
6th position 
S-CH2-CH2-SCH 
oC -Sulf inyl 
p-thio^at 
6th position 
S—CHp —CHT —SOO" 
oC -Sulfonyl 
p-thio^at 
6th position 
10 
10 
10 
0 
80 
34 
49 
39 
17 
24 
80 
29 
133 
145 
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Continued 
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s. 
No 
11 
12 
13 
Steroids 
Oxathiol-
ane Series 
XI 
XII 
XIII 
Structural 
difference 
0 
1) 
H3C-C-0-
gp at 3rd 
position 
Cl-gp at 3rd 
position 
No gp at 3rd 
position 
Dose of 
steroid 
plate) 
TA97a TA98 
Strains 
TAIOO TA102 TA104 
0 
0 
92 
ND 
ND 
ND 
162 
130 
204 
172 
266 
258 
185 
215 
625 
*-The numbers represent histidine revertants per plate. 
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TABLE 4. Relevant Genet ic and Biochemical markers of Ames 
t e s t e r s t r a i n s . 
S . 
No 
M a r k e r s 
TA97a TA98 
S t r a i n s 
I TAIOO TAX 02 TAX 04 
X. 
6. 
7. 
8. 
9. 
Type of mutation 
Location of 
mutation in 
his^idine gene 
Excision-repair 
Loss of poly-
saccharide layer 
(rfa) 
R-factor plasmid 
Base-pairs at 
the site of 
reversion 
Antibiotic 
resistance 
Spontaneous rev-
ersion frequency 
Replacement of 
the strains 
Frame-
shift 
hisD66X0 
AUvrB 
rfa 
pKMXOX 
GC 
Amp-* 
90-X80 
TAX537 
Frame-
shift 
hisD3052 
AUvrB 
rfa 
pKMXOX 
GC 
Amp^ 
30-50 
TAX538 
Base-
pair 
substi-
tution 
hisG46 
AUvrB 
rfa 
pKMXOX 
GC 
Amp^ 
X20-200 
TAX535 
Transi-
tion 
hisG428 
Ochre mu-
tation on 
a multi 
copy 
plasmid, 
pAQX 
uvrB 
profi-
cient 
rfa 
pKMXOX, 
pAQX 
AT 
Amp^,Tet-'^ 
240-320 
-
Transi-
tion 
hisG428 
on the 
chromo-
some 
extra 
AUvrB 
rfa 
pKMXOX 
AT 
Amp''^  
350±75 
-
Symbols : A - deletion 
f - resistent 
CHAPTER IV : ROLE OF SOS REPAIR AND 
MUTAQENESIS IN STEROID-
INDUCED INJURY 
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Introduction 
Various physical and chemical environmental agents have 
been shown to damage cellular DNA in vivo. The capacity 
of a system to repair such damage is basic to the 
ability of an organism to withstand the biological 
stress. Correctly repaired, genetic damage has little 
effect on the biological function of a system. Studies 
on living cells have shown that DNA damage results in 
change in the physiological processes such as growth, 
division, transcription of DNA, cell death, mutation and 
induction of transformation (Elkind and Whitmore, 1967; 
Price and Makinodan, 1973; Lohman and Bootsma, 1974). 
E. coli responds to DNA damage with the expre-
ssion of a set of functions usually termed as ^SOS -
response'. This includes the induction of a transitory 
mutagenic DNA repair system, the activation of inducible 
prophage and of several other functions involved in cell 
division and DNA metabolism (Radman, 1974; Witkin, 1976; 
Strauss, 1989). 
Several methods have been developed to 
estimate the extent of DNA damage for determining the 
mutagenic potential of a chemical based on the expressi-
on of SOS genes in treated E.coli cells (Moreau et al. . 
1976; Bagg et a^. , 1981; Kenyon and Walker, 1981). 
These systems are arbitrarily called "Induct test. Mud 
test, Chromotest", etc. 
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The work embodied in this chapter was, 
therefore, planned to estimate the extent of injury 
brought about by steroid treatment and to understand 
their mutagenic behaviour in terms of SOS - functions in 
E.coli cells. 
Our contention was that SOS-defective strains 
of E.coli K-12 as well as lambda and Mud lysogens might 
serve as convenient models for this purpose because even 
a slight change in the environment could be reflected in 
their survival, expression of SOS - genes and plaque 
forming capacity. 
Materials and Methods 
Bacteria, the lysogenic strains, media, test steroids 
and buffers are listed in Chapter II. Relevant genetic 
markers associated with the strains are also given in 
Chapter II. Survival patterns of E.coli strains, induc-
tion of prophage lambda and Mud test have been studied 
in the presence of steroids I, V, VII and IX only since 
these steroids were more mutagenic based on Ames 
testing. 
The SOS-defective E.coli strains and lysogen 
'XcI857/HB101' were treated with that concentration of 
the steroid at which the peak (maximum mutation frequen-
cy) was observed in Ames testing. Except where otherwi-
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se stated, the E.coli cells were treated for 6h. All the 
media were freshly prepared. 
Treatment of E.coli K-12 with Steroid; The SOS-
defective, recA and lexA mutants of E.coliK-12 as well 
as the isogenic wild type strain were harvested by cent-
rifugation from exponentially growing culture (i - 3 x 
10^ viable counts ml"-'-) . The pellets so obtained were 
suspended directly in O.OIM MgSO^ solution and treated 
with 0.5 and 0.6 ;ag per ml culture of the test steroids 
separately. Samples were withdrawn at regular 
intervals, suitably diluted and plated to assay colony-
forming ability. Plates were incubated overnight (0/N) 
at 37°C. Solvent controls were also run simultaneously. 
/^-Prophage Induction in the Presence of Steroid; Expone-
ntially grown lysogen 'XcI857/HB101' (1 - 4 x 10^ viable 
^ ounts ml"-^ ) was centrifuged, washed and resuspended in 
C.OIM MgSO^ solution. The resuspended culture was trea-
w".d with the test steroids separately and incubated at 
3 °C for 3 h. The cells were again centrifuged, washed 
ai i resuspended in nutrient broth with and without chlo-
ra iphenicol (100 ug ml"-^ ) and incubated for the next 3 h 
at 32°C. Aliquots were taken out at regular intervals, 
suitably diluted and plated with C600 cells. The 
plaques were scored after 0/N incubation at 42°C. Simu-
ltaneously, the control was also run taking the solvent 
only. 
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Induction of p - Galactosidase; The C600AIF#2 cells were 
grown exponentially in LB/Ca"*"^  broth (5x10^ viable 
counts ml"-^ ) and chilled rapidly. Aliquots (0.2 ml) of 
the phage dilutions were treated with steroidi and 
solvent (as control) and mixed with 0.2 ml aliquots of 
the cells. The treated phage - bacterial complexes were 
incubated at room temperature for 30 min after which 0.1 
ml of each mix was spread over Mg minimal agar plate 
supplemented with ampicillin (25 >ug/ml) and X-gal(40 
jug/ml)• The plates were incubated 0/N at 30°C. Deriva-
tives having Mud (Ap, lac) insertions in genes of inter-
est were identified by screening mutated blue colonies 
out of the noirmal white ones. 
Assay of p - Galactosidase Activity; Exponentially grown 
cells of C600 A IF #2 (5x10^ viable counts ml~^) in Mg 
medium were rapidly chilled and incubated at 37°C for 30 
min over a shaker. After resuspending the culture in 
fresh Mg medium, the cells were infected with fresh 
lysates of Mall03 and Mal315 and treated with steroid I 
and solvent (as control) separately for 20 min at 37°C. 
After centrifugation, the pellets so obtained were 
resuspended in equal volume of fresh Mg medium and 
incubated at 37°C over a metabolic shaker. At 0 h, 0.1 
ml of treated bacteria and phage - bacterial complexes 
were mixed with 0.1 ml Z-buffer containing a drop of 
toluene, vortexed and incubated for the next 20 min at 
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37°C. Toluene was allowed to evaporate by placing the 
tubes over a rotary shaker at 37°C for 40 min with tops 
open. The tubes were then kept in water bath at 28 °C 
for 5 min. The reaction was started by adding X-gal(40 
jug/ml) to the mixture. The tubes were occasionally 
vortexed. After the development of sufficient blue 
colour, the reaction was stopped by adding 0.1 ml IM 
Na2C03 to each of the tubes. 
The same procedure was followed for 2,4 and 6 
h incubation. Benzo *a' pyrene was used as a positive 
control. 
The samples were read at 600 nm with a Pye-
Unicam PU8800 UV/VIS Spectrophotometer. 
The p- galactosidase activity was expressed in 
units of: 
°*^600nm 
Time/jjjj^yjj X Volume of o r i g i n a l 
c u l t u r e 
X 1000 
Results 
Survival of E.coli K-12 treated with steroids: The surv-
ival patterns of recA and lexA mutants of E.coli in the 
presence of steroids are shown in Fig. 1 (A-D) . Both 
mutants exhibited a significant decline in their colony 
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forming units (CFU) compared with their wild-type 
counterpart. The lexA mutant was found to be more 
sensitive compared with the recA mutant. Moreover, it 
was observed that upto 2 h incubation of the lexA mutant 
in the presence of steroids VII and IX, there was no 
significant damage but after 6 h of incubation, a signi-
ficant decline in CFU was observed compared with the 
wild-type. The survival patterns of strains in the 
presence of steroid I after 6h treatment was (recA, 
49.8%; lexA. 8.0%; wild-type, 90.2%). 
The steroids could be listed in order of their 
potency towards the mutants as follows: 
I > V > VII > IX 
>>,-Prophaae Induction in the Presence of Steroids: Table 
1 shows the induction of X prophage as a result of 
steroid treatment of lysogen during the post-treatment 
liquid holding in the nutrient broth. A fraction of the 
lysogenic population exhibited induction of a lytic 
cycle during the liquid-holding at 3 2''C. Moreover, it 
appeared that the extent of induction was directly 
related with the dose of the steroids. There was no 
significant increase in the prophage induction over and 
above the background level in the untreated control as 
well as in the chloramphenicol-supplemented treated 
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samples. Similar trend of potency of the steroids 
towards the lysogen was observed here as was observed in 
the survival pattern i.e. steroid I > V > VII > IX. 
Induction of p-Galactosidase in the Presence of steroid 
I.: The lac gene expression of Mall03 strain after 
treatment with steroid ( 3 wg/plate ) in solid indicator 
plates was studied. Out of 289 colonies carrying Mud 
(Ap, lac) insertions, 89 displayed substantially greater 
p-galactosidase activity after treatment. There was a 
2.2 fold-induction of lac genes in the presence of 
steroid compared with the control. 
Kinetics of steroid I and benzo *a^  pyrene induction of 
p-qalactosidase in fusion strains: Figs. 2(A-D) and 
3(A,B) show the kinetics of steroid and benzo^a' pyrene 
at the indicated doses. The CgQQAIF #2 host strain 
together with phage lysate induced a significant level 
of p-galactosidase activity after treatment. The 
untreated host strain showed no B-galactosidase activity 
upto 6h incubation whereas the treated host strain 
exhibited maximum activity. 
Induction of p-galactosidase was dose as well 
as time dependent (Fig.2(A-D)). Moreover, the response 
of steroid was similar to benzo*a' pyrene (Fig.3(A,B)). 
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Discussion 
Cellular DNA damage occurs following exposure to 
ultraviolet light, ionizing radiation, various environm-
ental chemicals and reactive oxygen species. If left 
unrepaired, it can result in cell death, mutation and 
neoplastic transformation. Prokaryotes and eukaryotes 
have evolved systems for reversing DNA damage, and 
several classes of DNA repair enzymes have been identif-
ied (Friedberg and Bridges, 1983). 
Since it is always desirable to carry out 
various types of tests to predict the actual behaviour 
of the test compound (Maron and Ames, 1983) we have, 
therefore, employed other systems in prokaryotes only 
like the E.coli. lambda and Mud for relatively potent 
steroids detected on the basis of Ames test. 
It is postulated that the inducible error 
prone repair pathway presumably involving recA and lexA 
genes could potentially operate on several types of 
lesions in DNA (Walker, 1985; Strauss, 1989). The recA 
and lexA mutants of E.coli were found to be highly sens-
itive to the test steroids (Fig. 1) suggesting thereby 
the damage to the DNA of the exposed cells as well as 
the role of recA and lexA genes to cope with their 
hazardous effect. The role of recA and lexA in initiat-
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ing the error prone repair in E.coli is well documented 
(Walker, 1985). This idea gains further support from 
the induction of prophage in the X'^Y^ogen (Table 1) 
and by Ames testing studies (Tables 1,2 and Figs-1-9 of 
Chapter III) with the Salmonella strains triggering the 
error-prone SOS - response (Little et. aJ., 1989). 
Moreover, the SOS-repair, similar to our case has been 
shown to essentially require the de novo protein biosyn-
thesis for its initiation (Table 1; Witkin, 1976). 
Prophage induction by UV and X-ray is well established 
and is considered to be one among the many SOS-responses 
(Witkin, 1976). 
Because the induction of SOS-function can be 
triggered by a diverse array of DNA damaging treatments 
(Kenyon and Walker, 1980), the effect of steroid I was 
also tested for induction of p - galactosidase in the 
C600 A IF # 2 and Mud (Ap, lac) fusion strains. Mu is a 
bacteriophage that, like X' ^^^ integrate into the 
chromosome of E.coli and make a repressor that prevents 
the expression of the rest of the phage genes. However, 
unlike X, which integrates preferentially at a single 
site in the E.coli chromosome, Mu integrates essentially 
at random (Danielli et al., 1972). The Mud (Ap, lac) 
bacteriophage is missing some of the genes of Mu and in 
their place carries a p-lactamase gene complete with its 
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own promoter, so that when Mud (Ap, lac) integrates into 
the chromosoine that cell becomes resistant to 
ampicillin. In addition, the Mud (Ap, lac) bacteriopha-
ge carries the structural genes for the lac operon, but 
no promoter for these genes; furthermore, there is no 
promoter on the Mu DNA upstream of the lac genes. Thus 
the lac genes can be expressed only if Mud (Ap, lac) 
inserts in the correct orientation into a bacterial 
transcriptional unit. In such a fusion, the expression 
of p-galactosidase (the product of the lacZ gene), 
permease (lacY ) and transacetylase (lacA) is controlled 
by the regulatory circuitry of that particular bacterial 
transcriptional unit (Krueger and Walker, 1983). 
The basic strategy for the isolation of 
fusions responding to the test steroid was to screen 
colonies of bacteria containing random Mud (Ap, lac) 
insertions for those that showed increased p-
galactosidase activity. Our result indicated a low but 
significant degree of p-galactosidase induction upon 
steroid treatment in solid indicator plates. 
Low levels of induction with indicator plate 
was also reported in case of mitomycin C (Kenyon and 
Walker, 1980). 
Since it has already been reported that in the 
presence of mitomycin C it was not possible to assess 
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the levels of lac gene expression accurately on indicat-
or plates and such isolates could be screened directly 
for induction (in the presence of DNA damaging agents) 
in liquid media (Kenyon and Walker, 1980) therefore the 
lac gene expression in the presence of the test steroid 
was also tested in the liquid medium. The kinetic 
studies further confirmed the p-galactosidase induction 
(Fig.2) which again supports for the induction of SOS -
response. Moreover, the kinetic response of Mud-lysogens 
with steroid! was similar to benzo^a' pyrene (Fig.3). 
This suggests that induction of the operon fusion gene 
products may occur as a result of a common signal that 
arises from both steroid and benzo^a' pyrene treatments. 
Our findings alongwith the elevated mutagenic 
response of the steroids with Salmonella strains 
(Chapter III) are consistent with the idea that the test 
steroids initiate the SOS - response and thus bring 
about the mutation in bacterial DNA. The DNA damage 
and/ or mutation with the concomitant SOS - like respo-
nse brought about by mutagenic steroids might also play 
an important role in the neoplastic transformation in 
the higher system. 
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TABLE 1. X~P^ophage induction on Steroid I,V,VII and IX treatment 
Time of 
incuba-
tion of 
lysogen 
in nut-
rient 
broth 
at 
32°C 
(h) 
Cont-
rol 
X-Prophage induction per 10° lysogens 
After steroid treatment for 3 h 
Dose of 
steroid I 
(ug/ml) 
Dose of 
steroid V 
(ug/ml) 
Dose of 
steroid VII 
( ug/ml ) 
Dose of 
steroid IX 
( ug/ml) 
0.5 1.5 0.5 1.5 0.5 1.5 0.6 1.9 
In the pr-
esence of 
different 
test ste-
roids (1.5 
;ag/ml) + 
chloramphe 
nicol(100 
JLig/ml) 
1 . 0 
1 . 0 
1 . 1 
1 . 1 
1 . 0 
2 . 2 
3 . 0 
3 . 1 
1 . 0 
2 . 9 
4 . 6 
5 . 0 
1 . 0 
1 . 6 
1 . 8 
2 . 5 
1 . 0 
1 . 7 
3 . 3 
3 . 9 
1 . 0 
1 . 7 
2 . 0 
2 . 3 
1 . 0 
1 . 7 
2 . 5 
3 . 5 
1 . 0 
1 . 0 
1 . 3 
1 . 7 
1 . 0 
1 . 3 
2 . 1 
2 . 3 
1.0 
1.0 
1.0 
1.0 
* The values represent fold induction with respect to the 
solvent treated control. 
(M) awu (Ml 3WU 
(M) 3HU 
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OS n 
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80 
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Fig. 3. Kinetics of p-galactosidase induction in 
the steroid treated (panel A) and 
benzo^a' pyrene treated (panel B) Mud 
lysogens. 
A, 60 jLig/ml 
B, 3 0 jag/ml culture 
Untreated C^QQAIF #2 host : O O 
Steroid/benzo^a' pyrene 
treated CgQoAIF #2 : • • 
Steroid/benzo^a' pyrene 
treated Mud I lysogen : Q O 
Steroid/benzo^a' pyrene 
treated Mud II lysogen : o O 
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Fig. 2. Effect of Steroid I treatment on the 
induction of p-galactosidase in Mud 
lysogen at various doses. The effect of 
solvent has been nullified. 
Steroid doses : A, 1 yg/ml; B, 3 ug/ml; 
C, 6 iig/ml; D,90 ug/ml. 
Untreated CgQQ^IF #2 host : O-
Steroid 
treated CgQQAIF #2 : • 
Steroid 
treated Mud I lysogen : © 
Steroid 
treated Mud II lysogen 
2 
< 
1 
§ 
100 
50 
10 
I '-
TIME (h) TIME ( h ) 
CHAPTER V : ROLE OP OXYGEN RADICAL SPECIES 
ON THE STEROID - INDUCED 
MUTAGENESIS 
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Introduction 
Damage to DNA is likely to be a major cause of cancer 
and other diseases (Hiatt et ai-, 1977; Ames, 1979). 
The Salmonella mutagenicity test (Ames et al., 1975; 
Maron and Ames, 1983), along with other short-term 
assays (Hollstein et al., 1979), is being used extensiv-
ely to survey a variety of substances in the environment 
for mutagenic activity. Oxygen radicals may be the most 
important class of mutagens contributing to aging and 
cancer (Ames, 1982; Yamamoto et ai., 1989), yet a number 
of oxidants known to generate reactive oxygen species 
were not detected as mutagens in the earlier standard 
Salmonella mutagenicity assays (Ames, 1971). The Salmo-
nella tester strain, TA102, was then described (Levin et 
al., 1982b) that detected a variety of oxidants and 
other agents as mutagens. The role of free radicals in 
the promotion of carcinogenesis had also been emphasized 
(Troll and Wiesner, 1985). 
As active oxygen species are known to cause 
DNA damage (Inoue and Kawanishi, 1987), the effects of 
oxygen radical scavengers on DNA damage induced by the 
test steroids were examined. Steroid I, displaying the 
maximum mutagenic activity among the aziridines tested 
on the basis of Ames test and steroid IX, displaying 
intermediate mutagenic activity among the dithiolane 
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series were tested for the production of oxygen radical 
species. Present chapter also describes the Ames test 
with the individual moieties/groups present in steroid I 
to ascertain whether or not a part of the test steroid 
molecule is capable of imparting the potent mutagenic 
activity. 
Methods 
Ames testing with Steroids I and IX in the Presence of 
Scavengers; The effect of oxygen radical scavengers on 
the mutagenic activity of test steroid in Salmonella 
typhimurium TA102 strain was studied employing the Ames 
testing system. The procedure is the same as described 
in the ^Methods' section of Chapter III. 
Ames Testing in the Presence of Different Moieties of 
Steroid I; Reversion of tester strains with different 
potential moieties present in steroid I was studied 
employing Ames testing system. 
Results 
The Effect of Catalase and Superoxide Dismutase on the 
Mutagenic Activity of Steroid I; The effect of catalase 
and superoxide dismutase on induction of histidine 
revertants of S.typhimurium TA102 strain at varying 
concentration of the steroid is shown in Table 1. A 
significant reduction in the colony forming ability of 
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histidine revertants was observed in the presence of the 
scavengers. 
A direct relation between the inhibitory 
effect of scavengers and the dose of the steroid was 
observed in the absence of Sg fraction but this type of 
relationship was not found in the presence of Sg fracti-
on. Moreover, the mutagenic activity of the steroid was 
inhibited more in the presence of catalase compared with 
that of superoxide-dismutase. One hundred percent 
inhibition was found with catalase and superoxide dismu-
tase at a dose of 15 Aig/plate of the steroid in the 
presence as well as in the absence of Sg fraction. 
The Effect of Hydroxyl Radical Scavengers on the 
Mutagenic Activity of steroid I; The effect of formate, 
mannitol and thiourea is shown in Table 2. The scaveng-
ers reduced the number of histidine revertants of 
S.typhimurium TA102 strain as the dose of the steroid 
was increased. The trend of inhibition by scavengers 
against dose of the steroid was again marked in the 
absence of Sg fraction as compared with that in the 
presence of Sg fraction. At a concentration of 5.0 
ug/plate of the steroid in the presence of formate and 
mannitol, there was complete (100%) inhibition whereas 
at the same dose with thiourea in the absence of Sg 
fraction, there was still 20% residual activity. 
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The Effect of Catalase and Superoxide Dismutase on the 
Mutagenic Activity of Steroid IX for S. typhimurium 
TA102; Table 3 shows the effect of catalase and superox-
ide dismutase on the histidine revertants of TA102 
strain at varying concentrations of the test steroid. 
The scavengers invariably reduced the colony-forming 
ability of histidine revertants. A direct relation 
between the inhibitory effect of scavengers and the dose 
of the steroid was observed in the absence of Sg 
fraction. Complete inhibition was found with catalase 
at a dose of 15 ug/plate of steroid in the absence of Sg 
fraction whereas at the same dose with superoxide 
dismutase, there was 10% residual activity. 
The Effect of Hydroxvl Radical Scavengers on the 
Mutagenic Activity of Steroid ixt The effect of formate 
and mannitol on the histidine revertants of 
S.typhimurium TA102 strain was studied at a fixed 
concentration of the steroid (Table 4). Increasing 
concentration of the scavengers resulted in the invaria-
ble reduction in the number of histidine revertants. 
This trend was again marked in the absence of Sg 
fraction. At a concentration of 16 jiag/plate of formate, 
the histidine revertants were equal to the spontaneous 
revertants. Mannitol also showed the same effect at the 
same dose. 
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Reversion of Ames Tester strains in the Presence of 
Different Moieties of steroid I: The reversion of 
tester strains with different potential moieties present 
in steroid I (la, lb, Ic) was studied (Table 5) . None 
of the test moieties exhibited significant amount of 
mutagenic activity. Presence of S^ fraction usually 
enhanced the mutagenic activity to some extent but the 
value was always much less than that for the parent 
compound (Fig. 1 and Table 2 of Chapter III) under the 
identical conditions. 
Discussion 
One of the theories on the etiology of cancer holds that 
the major factor induced by the carcinogen is the damage 
to DNA by oxygen radicals and lipid peroxidation 
(Totter, 1980; Ames, 1983). Exposure of DNA to superox-
ide radical ( O2 ) generating systems causes extensive 
strand breakage and degradation of deoxyribose (Brawn 
and Fridovich, 1981) probably due to the formation of 
•OH radicals. Oxygen radicals have been suggested to be 
involved in the action of a number of DNA- damaging 
drugs (Lown et al., 1982). Oxygen radicals may be the 
most important class of mutagens contributing to aging 
and cancer (Ames, 1982). The Salmonella tester strain, 
TA102, detects a variety of oxidants and other agents as 
mutagens (Levin et al., 1982b). Our data are consistent 
with the idea that the test steroids somehow generate 
the active oxygen species in the system. 
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steroid I, displaying the maximum mutagenic 
activity among aziridines and steroid IX, displaying 
intermediate mutagenic activity among the dithiolane 
series were investigated for the production of oxygen 
radical species by means of Ames test. The test 
steroids appear to generate hydrogen peroxide and 
reactive oxygen radical species, 'OH and Oj in the 
test system. In fact, inhibition of the mutation frequ-
ency of strain TA102 with test steroids in the presence 
of catalase and superoxide dismutase suggested that the 
steroids probably somehow generate hydrogen peroxide and 
6^ radical (Tables 1 and 3). Such protection by both 
catalase and superoxide dismutase has been reported in 
many cases (Michelson et al., 1977; Halliwell, 1981). 
Besides the protective effect of catalase and 
superoxide dismutase, we have also found inhibition of 
the mutagenic activity with the 'OH radical scavengers 
sodium formate, mannitol and thiourea (Tables 2 and 4) 
which suggests the formation of hydroxyl radicals too in 
the test system. 
Gutteridge (1984) and Goldstein and Czapski 
(1986) have suggested that the O2 radical could also 
serve as a precursor for the 'OH radical. 
The overall reaction might have been possible 
according to the following Haber-Weiss reaction (Haber 
and Weiss, 1934): 
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Several reports have shown that "OH formation 
can be accounted for if the Haber - Weiss reaction is 
catalysed by traces of transition metal ions (Halliwell 
and Gutteridge, 1984). Misra and Fridovich (1976) have 
suggested that the Haber-Weiss reaction is catalysed by 
components of the bacterial surface. Since iron salts 
are available in vivo (Gutteridge, 1984; Halliwell and 
Gutteridge, 1984) , a plausible mechanism can be written 
as follows: 
Fe^ "^  + O2 > Fe^ "*" + O2 
(©2 reducing the iron salt) 
Fe^ "*" + HoOo > Fe-^"*" + -OH + "OH 
( Fenton reaction ) 
Net: O2 + H2O2 > O2 + 'OH + "OH 
Fe salt 
Catalyst 
( Iron-catalysed Haber-Weiss reaction ) 
Hydroxyl radicals once generated will react 
with the molecule in their immediate surroundings. 
Superoxide and H2O2 are less reactive and can diffuse 
away from their sites of formation leading to 'OH gener-
ation in different parts of the cell whenever they meet 
a ^spare' transition metal ions (Halliwell and Gutterid-
ge, 1984). 
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A possible source of 'OH radicals and H2O2 in 
the case of the test steroids is summarized in Figs 1 
and 2. As is obvious from the mechanism presented in 
Fig. 1, the hemolytic fission of XOOH in dithiolane 
steroids can also give rise to XOO* and 'OOH radicals 
and thus the observed reduction in genotoxicity upon the 
addition of scavengers may also well be attributable to 
the trapping of alkokyl (XOO*?) and/or peroxyl (-OOH) 
radicals but the presence of alkokyl radical appears to 
be a very remote possibility in view of the highly polar 
nature of the living system because for that the ^X' has 
to be essentially an alkyl group. The hemolytic fission 
of the indicated species in the case of aziridine 
steroids might yield hydrogen peroxide and hydroxyl 
radicals as well as carbon-centered (CH3-C*) radical 
(Fig. 2). 
There is at least one precedent for such a 
possible mechanism. Nakayama et al (1983) showed that 
free radical reaction might account for the carcinogen-
icity/mutagenicity of naphthylamine and amino-azo dyes. 
Spectral studies of the dithiolane steroids (Shafiullah 
et ai., 1983) supports the idea that the halogen, being 
an electronegative element, might enhance the electroph-
ilic potential of the sulfur present in the derivatives 
(Table 3 of Chapter II). 
The higher decrease in genotoxicity observed 
when these assays were carried out in the presence of 
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liver microsomal fraction compared with those without 
(Tables 1 - 4 ) further suggests that the Sg dependent 
reactive species may be different from those formed 
chemically. 
Our results (Table 5) also indicated that the 
individual moieties/groups were not mutagenic per se. 
Their association with the steroidal nucleus made them 
remarkably mutagenic (Fig. 1 and Table 2 of Chapter III) 
with the probable involvement of various oxygen radical 
species in the biological system. 
Present studies support the idea that oxygen 
radical formation in the living system increases the 
risk of chemical carcinogenesis and certain steroids 
might be instrumental in the causation of cancer. 
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TABLE 1 . Effects of Catalase and Superoxide dismutase 
on the Mutagenic Activity of Steroid I for S. 
typhimurium TA102 
Scaven-
ger 
Cata-
lase 
(16 jag/ 
plate) 
Super-
oxide 
dismu-
tase 
(40 jug/ 
plate) 
Dose of 
steroid 
(ug/ 
plate) 
0 
0.25 
1.0 
5.0 
15.0 
0 
0.25 
1.0 
5.0 
10.0 
15.0 
Histidine"*" revertants/plate ^ 
-Sg 
-Scaven 
ger 
-
120 
189 
340 
165 
-
120 
189 
340 
190 
165 
+Scaven 
ger 
-
30 
31 
29 
0 
-
95 
104 
84 
10 
0 
+S9 
-Scaven 
ger 
-
345 
980 
712 
120 
-
345 
980 
712 
245 
120 
+Scaven 
ger 
-
13 
22 
63 
0 
-
180 
170 
76 
60 
0 
Relative^ 
activity 
(%) 
-Sg 
100 
25 
16 
9 
0 
100 
79 
55 
25 
5 
0 
+S9 
100 
4 
2 
9 
0 
100 
62 
17 
11 
24 
0 
a Spontaneous revertants have been subtracted. 
b Relative activity was calculated with respect to 
the corresponding dose of the steroid taking 
the value in the absence of scavenger as 100%. 
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TABLE 2 . Effects of Formate, Mannitol and Thiourea on 
the Mutagenic Activity of Steroid I for S. 
typhimurium. TA102. 
Scaven-
ger 
Amount 
of 
steroid 
(wg/ 
plate) 
Histidine"^ revertants/ 
plate ^ 
-S, +s, 
Relative^ 
activity 
(%) 
-Sg I +S9 
No 
Scaven-
ger 
Formate 
(40 ug/ 
plate) 
Manni-
tol 
(40 yxq/ 
plate) 
Thio-
urea 
(40 ug/ 
plate) 
0.5 
1.0 
5.0 
10.0 
0.5 
1.0 
5.0 
10.0 
0.5 
1.0 
5.0 
0.5 
1.0 
5.0 
10.0 
156 
189 
340 
190 
38 
20 
0 
0 
55 
08 
0 
173 
123 
68 
0 
535 
980 
712 
245 
10 
68 
07 
0 
122 
0 
0 
77 
177 
65 
0 
100 
24 
11 
0 
0 
35 
4 
0 
111 
65 
20 
0 
100 
2 
7 
1 
0 
23 
0 
0 
14 
18 
9 
0 
a Spontaneous revertants have been subtracted. 
b Relative activity was calculated with respect to 
the corresponding dose of steroid taking the 
value in the absence of scavenger as 100%. 
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TABLE 3. Effects of Catalase and Superoxide Dismutase on the 
Mutagenic Activity of Steroid IX for S. typhimurium 
TA102 
Amount of 
Scaven-
gers 
Catalase 
(16 ug/ 
plate) 
Superoxide 
dismutase 
( 40 ug/ 
plate) 
Dose of 
steroid 
( wg/ 
plate) 
0.25 
1.0 
5.0 
10.0 
15.0 
^ 5.0 
10.0 
15.0 
Histidine"*" revertants/plate^ 
-Sg 
-Scav-
enger 
65 
236 
267 
326 
195 
267 
326 
195 
+Scav-
enger 
36 
80 
84 
83 
65 
197 
44 
20 
+S9 
-Scav-
enger 
160 
350 
393 
510 
250 
393 
510 
250 
+Scav-
enger 
0 
64 
124 
0 
0 
214 
0 
0 
Relat 
acti\ 
(%) 
-Sg 1 
55.3 
33.8 
31.4 
25.4 
0 
73.7 
13.4 
10.2 
:ive" 
' xty 
+S9 
0 
18.2 
31.5 
0 
0 
54.4 
0 
0 
a Spontaneous revertants have been subtracted. 
b Relative activity was calculated with respect to corr-
espondij!^ dose of steroid taking the value in the 
absence of scavenger as 100% 
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Fig. 1. Survival of E.coli K-12 cells exposed to 
different test steroids. 
A 
B 
C 
D 
W.t 
recA 
lexA 
Steroid I 
Steroid V 
Steroid VII 
Steroid IX 
• • 
0 0 
9 9 
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TABLE 4. Effects of Formate and Mannitol on the Mutagenic 
Activity of Steroid IX for S. typhimurium TA102. 
Amount Dose of rever- Relative" 
of Scavengers scaven- Histidine"*" tants/ activity 
steroid gers plate (%) 
( jag/ 
plate -Sg +Sg -Sg +Sg 
(10 ug/ Formate 0 326 510 100 100 
plate) 
4 60 47 18.4 9.2 
8 28 49 8.* 9.5 
16 0 56 0 10.9 
24 0 0 0 0 
(10 jug/ Mannitol 0 326 510 100 100 
plate) 
2 97 17 29.7 3.3 
4 34 21 10.4 4.1 
8 30 0 9.2 0 
16 0 0 0 0 
a Spontaneous revertants have been subtracted. 
b Relative activity was calculated with respect to 
corresponding dose of steroid taking the value in the 
absence of scavenger as 100%. 
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X-O-O-^H 
1 
XOO' + H 
or 
Xj- O - O - H 
1 
x' + boH 
homol^tic 
f ission 
X 
or 
f unst Gbte 
XO + [OH 
' O H 4 - b H - H,0 , 
XOH : reac l ive nucleophile (wi thm cell •>) 
Y : halogen (equitorml ">) 
.v-> : enhancing Ihe electrophi he nature of S mo ie l y 
Fig. 1 . Possible mechanism of mutagenic action of test 
steroids (III — X ) 
I l l 
HX-C-0 '° a-./e 
S t e r l c 
hindercnce 
S"l7 
(B) 
r ^ 
\0.. X-O-H 
t-Q-H 
If . . 8 
KC-C-O^O-Ci-CK 
0 
II 
^-x + I OH 
Qstable 
HX-C-O-X ^ OH 
s t a b l e 
Most 
kirobable 
0 o, 
H3C-C- * X-0\(>H 
I u n s t a b l e 
xo •OH 
3 
jProbabl* 
Hf-:-c-o-o-c-CH 
i h . f . 
RC-C-C-CH. 
or 
X^O-O-H X-O-O^ H 
4 or 4 
X^bOH XOO»H 
^Least 
probable 
OH • OH-
"2°: 
A " s t e r o i d I ; B •• s t e r o i d a l moiety ( l b ) ; 
XOII » r o a c t l v c s p e c i e s ( w l t l i l n c e l l ? ) ; h . f . « h o m o l y t l c f i s s i o n ; 
^ « Double bond c h a r n c t c r . No p o s s i b i l i t y for c l e a v a R c at t h i s po int and thus 
no format ion of n u l l c a l s . 
Fig. 2 . Possible mechanism of mutagenic action of 
t e s t s t e ro ids ( I & II ) . 
CHAPTER VI ; INTERACTION OF STEROID-IWITH 
DNA: iii vitro Studies 
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Introduction 
DNA damage has been proposed as a potentially useful 
parameter in screening chemicals for their genotoxic 
properties, since many chemical carcinogens and mutagens 
have been shown to produce DNA damage in mammalian cells 
(Ewig and Kohn, 1977; Schwarz et al., 1979). Some forms 
of DNA damage (e.g., deoxyribonucleoside - chemical 
adducts) have been suggested as the initiators of 
chemical carcinogenesis (Brookes, 1977; Lutz, 1979). 
One particularly common type of DNA damage,strand break-
age (resulting from the hydrolysis of the phosphodiester 
linkage) is produced by a variety of chemical and 
physical agents and thus may be useful as an analytical 
parameter for assessing the exposure of the genetic 
material to genotoxic chemicals (Stich et ai., 1979). 
Hydroxyapatite chromatography is one of the 
efficient procedures which has gained widespread use in 
the study of nucleic acids (Bernardi, 1971). Its most 
popular analytical application is the separation of 
single stranded and double stranded DNA (Kohne and 
Britten, 1971; Martinson, 1973). This technique is 
based on the fact that denatured nucleic acids have less 
affinity for hydroxyapatite than their double stranded 
counterparts (Martinson, 1973). 
Since the concept of DNA strand separation 
during thermal denaturation was introduced (Doty et al.. 
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1960; Marmur and Lane, 1960), many methods utilizing 
denaturation have contributed to the study of DNA 
structure. S^ nuclease has been used to determine the 
thermal melting profile through digestion of denatured 
strands (Case and Baker, 1975; Rizvi et al., 1982). The 
DNA strand separation during thermal denaturation can 
also be determined directly using spectrophotometer 
coupled with a temperature programmer and controller 
assembly (Hasan and Ali, 1990). 
S-j^  nuclease, on the other hand has been widely 
used in the study of DNA secondary structure through a 
variety of approaches (Shishido and Ando, 1972, 1980; 
Thomas et al., 1984). It hydrolyses single stranded 
regions in duplex DNA and also detects locally altered 
structures (minor distortions) introduced by physical 
and chemical procedures (Shishido and Ando, 1982). 
Kanter and Schwartz (1979) have described an 
alkaline unwinding assay for quantitation of strand 
breakage in cellular DNA which uses hydroxyapatite in a 
batch procedure. The assay is based on the observation 
that the DNA molecule, when exposed to alkaline 
conditions beyond the helix-coil transition range (pH > 
11.5) undergoes strand separation, i.e. unwinding at 
each formal strand break (Daniel et al., 1985). 
This chapter deals with the studies on the 
mechanism of interaction of steroids with calf thymus 
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and plasmid DNAs to determine the nature of lesion(s). 
We have, therefore employed several techniques including 
those mentioned above. For this work, the potent 
mutagenic steroid (I) detected on the basis of Ames test 
was selected. 
Methods 
Hydroxyapatite Chromatoaraphv; Hydroxyapatite chrom-
atography of steroid-treated calf thymus DNA was 
performed as described by Bernardi (1971) . 200 jug DNA 
was treated with DNA bp/steroid molar ratio of 1:0.25, 
1:0.5, 1:1, 1:10 and 1:20 and incubated 0/N at 37°C. 
Samples were then loaded on the column (3x1 cm) and the 
elution was made with a stepwise gradient of sodium 
phosphate buffer (pH 7.0) containing 1% neutralized 
formaldehyde. 3.0 ml fractions were collected at the 
rate of 10 ml/h. DNA eluted in various fractions was 
determined spectrophotometrically at 260 nm over Beclcman 
DU40 spectrophotometer. 
Determination of melting temperature(Tm); Tm was deter-
mined as described by Hasan and Ali (1990). 500 jug calf 
thymus DNA was treated with different DNA bp/steroid 
molar ratios and incubated 0/N at 37 °C. The Tm of 
native, solvent/steroid-treated DNA was determined by 
Shimadzu UV 240 spectrophotometer coupled with a temper-
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ature programmer and controller assembly. The polymer 
in TN buffer was heated at the rate of 1°C per min 
initiating from SCC upto 95°C. The absorbance was read 
at 260 nm and the percent denaturation evaluated with 
increase in temperature. 
Percent denaturation (%D) was calculated as 
under: 
%D= 
Absorbance - Absorbance 
(observed)TC (initial) 
Absorbance - Absorbance 
(observed) (at 95°C) 
100 
Estimation of DNA and acid soluble nucleotides; DNA 
nucleotides, made acid soluble, were determined by the 
diphenylamine method of Schneider (1957) or spectrophot-
ometrically measuring the absorbance at 260 nm. To a 
1.0 ml aliquot, 2.0 ml of diphenylamine reagent (freshly 
prepared by dissolving 1.0 gm of recrystallized 
diphenylamine in 100 ml of glacial acetic acid and 2.75 
ml of cone. H2SO4) was added. The tubes were heated in a 
boiling water bath for 20 min. The intensity of blue 
colour was read at 600 nm using spectronic 20 Bausch and 
Lomb Spectrophotometer. To determine the acid soluble 
material spectrophotometrically, an aliquot of the 
supernatant was suitably diluted and read at 260 nm 
using spectronic 21 UVD Bausch and Lomb Spectrophotomet-
er against a suitable blank. 
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Sj^  nuclease assay of steroid-treated DNA: A 2 mg/ml 
solution of calf thymus DNA in TN was treated with 
steroid at desired concentration. The mixture was incu-
bated at 37 °C for 4h. The treated DNA was dialysed 
against 100 volumes of TN buffer at 4°C. The enzyme 
assay was done in terms of acid soluble nucleotides, 
released from DNA as a result of enzymic digestion. The 
S-|L nuclease reaction mixture in a total volume of 1.0 ml 
contained 500 jag substrate (native, denatured or 
steroid/solvent-treated DNA), 0.1 M acetate buffer pH 
4.5, 1 mM zinc sulphate, water and 30 units of S^ 
nuclease. The mixture was incubated for 2h at 48°C. 
The reaction was terminated by adding 0.2 ml 10 mg/ml 
bovine serum albumin and 1.0 ml 14% perchloric acid 
(ice-cold). The tubes were immediately transferred to 
0°C for at least Ih before centrifugation to remove the 
undigested DNA and precipitated protein. Acid soluble 
DNA nucleotides were determined in the supernatant using 
the diphenylamine method of Schneider (1957). 
Preparation of denatured DNA; Denatured DNA was prepar-
ed by heating native calf thymus DNA (2 mg/ml in TN 
buffer) at 100 °C for 9 min and cooling the solution 
rapidly in an ice bath (Verly and Lackroix, 1975). 
Allcaline unwinding assay; The assay was performed as 
described by Kanter and Schwartz (1979). Incubations 
with test steroid were carried out in volumes of 0.25 ml 
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containing 200 ug calf thymus DNA and steroid in the 
desired DNA bp/steroid molar ratio. The duration for 
the alkaline unwinding of the reaction mixture was 30 
min. The "unwound neutralized" reaction mixtures were 
then analysed by hydroxyapatite chromatography. The 
elution was made with a stepwise gradient of potassium 
phosphate buffer (pH 7.0) containing 20% formamide. DNA 
in eluates was measured spectrophotometrically at 260 
nm. 
Calculation: According to Rydberg (1975), the relation-
ship between strand separation of duplex DNA in alkali, 
where randomly distributed breaks are introduced, is 
-K 
In F = tP 
Mn 
where F is the fraction of double-stranded DNA remaining 
after alkaline denaturation for time t, and K is an 
assumed constant for rotational and frictional forces. 
Mn is the number-average molecular weight between 
unwinding points and p is a constant less than 1. 
From the above expression, Kanter and Schwartz 
(1979) have derived the following expression for calcul-
ating the number of unwinding points (P) per alkaline 
unwinding unit of DNA 
In Fx 
P = 
In Fo 
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where Fx and Fo are the fractions of double stranded DNA 
remaining after alkaline denaturation of treated and 
untreated samples, respectively. The number of breaks 
(n) per unit DNA is, therefore, 
n = P - 1 
DEAE -Sephadex A-50 Chromatography: The chromatography 
was performed as described by Hasan and Ali (1990). 150 
Aig calf thymus DNA was treated with steroid with a DNA 
bp/steroid molar ratio of 1:0.5 and incubated 0/N at 
room temperature. Excess of steroid was removed by 
exhaustive dialysis against phosphate buffered saline. 
In order to determine the extent of DNA base modificati-
on, the steroid - treated polymer was precipitated with 
ethanol. The precipitate after dessication was dissolv-
ed in perchloric acid (60%) and treated at 100°C for Ih 
to release the bases. After the solution was neutraliz-
ed, it was applied onto a column of DEAE Sephadex A-50 
and eluted with 0.02M Tris buffer, pH 7.2 at the flow 
rate of 40 ml/h. A total of 165 fractions of 1.5 ml 
were collected and their absorbance recorded at 260 nm. 
The control experiments were carried out with a mixture 
of equimolar concentration of individual bases in order 
to locate the elution pattern of unmodified bases. The 
individual modified/unmodified bases were identified by 
their characteristic UV - absorption profile. 
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Degradation of olasmid DNAt 0.3 xig plasmid DNA(psk, 6 
Kb) was treated with different concentrations of the 
steroid and incubated at 37 °C for 2h. The treated 
samples were dialysed over 0.025 mn millipore filter 
paper (a gift from Dr.J.H. Parish) . For the S-j^  nuclease 
digestion reaction, 3 units of enzyme was added to the 
reaction mixture. The reaction was terminated by the 
addition of bromophenol blue dye (20% sucrose, 0.25% 
bromophenol blue, 2% SDS). Solvent as control was also 
run simultaneously. 
Agarose gel electrophoresis! The psk-treated digests 
were applied on the wells. Vertical slab gel electroph-
oresis was carried out using 0.7% agarose. The slab gel 
was pre-electrophoresed at 60 mA for 30 min and the 
normal run was performed at 10 mA in electrophoresis 
buffer (0.04M Tris acetate; 0.002M EDTA) for 3-4h. The 
DNA bands were stained with ethidium bromide and fluore-
scent profile was photographed by UV illumination 
through fotodyne UV 300 transilluminator. 
Results 
Hydroxyapatite Chromatography; Fig.l shows the chro-
matogram of the steroid-treated DNA. The solvent-
treated DNA (as control) eluted in two major peaks corr-
esponding to 0.20 M and 0.25 M phosphate buffer (panel 
A). The two elution patterns were remarkably different. 
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The peak eluted at 0.25M buffer with the control was 
significantly reduced at the DNA bp/steroid molar ratios 
of 1:0.25 and 1:0.5 indicating the reduction of ds DNA 
in the steroid - treated samples (panels B and C) . On 
the other hand the peak at 0.20 M was significantly 
increased in the treated DNA indicating a higher percen-
tage of single strandedness. However, at the molar 
ratio of 1:>5, the pattern was remarkably different both 
qualitatively and quantitatively (data not shown). 
Thermal melting profiles of steroid-treated DNA: Fig. 2 
shows the thermal melting profile of DNA modified by 
steroid at DNA bp/steroid molar ratios of 1:0.25 and 
1:3. The melting temperature of native DNA was determi-
ned to be 76.5°C under our experimental conditions. The 
Tm of solvent-treated DNA (as control) was found to be 
69°C. However, a reduced Tm was obsexrved (59.5°C) at 
the molar ratio of 1:0.25. Moreover, there was signifi-
cant denaturation of treated DNA(1:0.25) even at 60°C 
exposure, suggesting the presence of some low melting 
regions in DNA. In contrast,at the higher molar ratio 
of 1:3 an increased value(88.5°C) was observed, indicat-
ing a sort of stabilization in secondary structure at 
high doses of steroid treatment. 
In order to further substantiate our results, 
an experiment shown in Fij.g. 3 was carried out. The 
control shows a normal thermal melting profile with a Tm 
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of 76.5°C whereas the steroid-treated DNA shows a Tm of 
88.5"C. Moreover, the treated DNA exhibited insignific-
ant denaturation upto 70°C contrary to more than 20% 
denaturation in the untreated DNA. When both untreated 
and treated DNA samples were subjected to heat-
denaturation and quickly quenched in ice before determi-
ning the melting profiles, the treated sample exhibited 
partial denaturation compared with the untreated 
control suggesting the appearance of interstrand cross-
links which lead to re-annealing of strands after heat 
denaturation. 
Sj^  nuclease hydrolYsis of steroid I treated DNA; DNA 
treated with increasing concentrations of steroid was 
subjected to hydrolysis by S-j^  nuclease. The results 
given in Table 1 showed that the production of acid 
soluble material increased with increasing dose of 
steroid (upto the dose ranging from 50uM to 250AIM) . 
Under the same conditions, native, solvent-treated and 
denatured DNA showed 22.03, 24.22 and 100 percent hydro-
lysis respectively. Thus steroid transforms DNA into an 
effective substrate for S-j^  nuclease. Interestingly, 
beyond the concentration of 250 ;aM a dose dependent 
reduction in the level of DNA hydrolysis was observed. 
Degradation of calf-thymus DNA treated with steroid I in 
the absence of Sj^  nuclease; To determine whether the 
hydrolysis of dsDNA after treatment could also be 
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steroid-mediated or was it S^ nuclease-mediated only, 
another experiment was performed in which the DNA was 
treated with steroid at various doses for 4h at 37°C and 
percent degradation determined in the absence of S^ 
nuclease. The results presented in Table 2 indicate 
that at lower doses of steroid (50 /UM - 150 pM) the 
degradation of DNA was enzyme-mediated (zero percent DNA 
degradation in the absence of S-j^  nuclease) but from the 
dose of 150 uM onwards the degradation presumably becomes 
steroid-mediated displaying a 50.6% DNA degradation with 
500 uM steroid treatment. 
Quantitation of DNA strand breaks by alkaline unwinding 
assay; Table 3 illustrates an experiment where DNA has 
been treated with increasing steroid/DNA bp molar ratio. 
The fraction of duplex DNA decreases in a linear fashion 
with increasing concentration of the steroid. The 
number of strand breaks formed per unit DNA increased 
correspondingly with steroid at low doses but at high 
dose (1:3), no appreciable increase in the number of 
strand breaks was observed. 
DEAE Sephadex A-50 Chromatographyt Treatment of native 
DNA with steroid resulted in the modification of thymine 
and cytosine (Fig.4). The extent of steroid modificati-
on was calculated from the elution profile by measuring 
the peak area and was found to be 47% for thymine and 
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35% in case of cytosine. Identification of different 
peaks was based upon the elution profile and the absorp-
tion spectra of individual bases under the identical 
conditions (data not shown). 
Electrophoretic pattern of steroid-treated plasmid DMA; 
In vitro treatment of plasmid DNA with steroid did not 
exhibit a remarkable change in the intensities of the 
three distinct forms of DNA in the absence of S-^ 
nuclease (Fig.5). At a dose of 150jaM, the intensity of 
supercoiled DNA band was greater than the relaxed/linear 
DNA whereas the 250jaM steroid treatment resulted in the 
reversal of intensities of the two bands (Fig.5A, lanes 
3 and 5) . However incubation with S-j^  nuclease after 
steroid treatment resulted in the complete elimination 
of -c-c-c- form with the concomitant appearance of 
linear species. Besides such type of alteration in the 
typical plasmidial structures, the smearing was also 
observed starting from the band corresponding to the 
linear species. At 50jiM steroid, the intensity of linear 
band was maximum and smearing was also observed. The 
intensity of the linear DNA band as well as smearing 
decreased with increase in the dose. To obtain a clear 
contrast between the three forms of DNA the same experi-
ment is shown in Fig.5(B and C) for comparison. 
Fig.5(D) shows the DNA degradation in the 
absence of S-^ nuclease. The solvent treated DNA (as 
124 
control) displayed the maximum population of supercoiled 
species plus weak band of the relaxed species (lane 1) 
whereas in the steroid-treated DNA, the intensity of 
both the supercoiled and relaxed/linear DNA decreased 
with increase of dose ranging from 50uM to 250JLIM but 
beyond 250uM concentrations, the DNA band was absent 
throughout the track (lanes 6 and 7). 
Discussion 
Hydroxyapatite chromatography is a well established 
procedure for fractionating single and double stranded 
nucleic acids (Ahnstrom and Erixon, 1981). A subtle 
difference in the secondary and tertiary structures of 
nucleic acids can also be discriminated by this techniq-
ue (Bernardi, 1971) . Our result indicated the alterati-
ons in the secondary structure of DNA caused by the 
steroid treatment (Fig.l). As is obvious from the 
figure, the control and treated DNA have different 
affinities of retention on the hydroxyapatite column. 
Increasing steroid/DNA bp molar ratio showed more 
strand-separation with concomitant decrease in the 
double stranded material. It seems plausible that the 
steroid treatment brings about a change in the configur-
ation of sugar phosphate backbone which is principally 
involved in modifying the adsorption affinity of ds 
nucleic acids. Similar explanation was also given for 
the DNA treated at high temperature (Martinson, 1973). 
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Our result also indicated a reduced Tm upon 
treatment of DNA with steroid at low dose but in 
contrast at high dose an enhanced Tm with respect to the 
control was observed (Fig. 2). These results can 
account for the destabilization of the duplex DNA, with 
the possible formation of single strand breaks at low 
dose of steroid treatment. However at higher concentrat-
ions of steroid, the formation of interstrand cross-
links seems to have occured. Similar type of Tm change 
was also observed on the treatment of DNA with 
methylglyoxal (Rahman et al.., 1990) . 
The induction of cross-links in DNA by steroid 
was further confirmed by another experiment. This tech-
nique was employed by Szybalski and Iyer (1967) to 
detect mitomycin induced cross-links between DNA strands 
(Hansjurgen and Gunter, 1978). The method is based on 
the fact that thermally denatured DNA will not reanneal 
to any significant extent under appropriate conditions 
unless both strands are held together by covalent cross-
links. The control showed a normal thermal profile with 
a Tm of 76.5°C. The Tm with strongly steroid-treated 
DNA was determined to be 88.5°C suggesting thereby the 
presence of interstrand crosslinks in the DNA (Fig. 3). 
Moreover, an insignificant strand separation even at 
70°C further supports the same idea. When both untreat-
ed and treated DNA samples were subjected to heat denat-
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uration and quickly quenched in ice before determining 
the melting profiles, the treated sample was found to be 
only partially denatured whilst the untreated control 
had undergone complete strands separation. These 
findings further support the previous explanation that 
interstrand cross-links might have formed at high doses 
of test steroid treatment to duplex DNA. 
The alkaline unwinding assay indicated an 
increase in the number of strand breaks formed per unit 
of DNA and decrease in the fraction of duplex DNA with 
the increase of the dose (Table 3) . But at high dose, 
neither increase in the number of strand breaks nor 
reduction in the fraction of duplex DNA was found. 
Strand breaks in DNA have also recently been reported 
upon treatment with silicic acid, furfural and 
methylglyoxal ( Khan et al., 1988; Hadi et al., 1989; 
Shahabuddin et al., 1990). The results obtained by the 
test steroid are in support of our earlier explanation 
that low doses of steroid might cause the formation of 
ssbs^and interstrand crosslinks are introduced only at 
higher doses. The results obtained in this experiment 
can be explained by the fact that the alkaline unwindi-
ng assay would be unable to detect strand breaks in a 
DNA molecule, which also contains interstrand cross-
links. 
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We have employed single strand specific 
nuclease to further study the distortion in the seconda-
ry structure of DNA. It has been reported that S^^ 
nuclease hydrolyse single stranded regions in duplex DNA 
and also detects locally altered structures (minor 
distortions) introduced by physical and chemical proced-
ures (Shishido and Ando, 1982). Our results indicated 
an appreciable increase in the production of acid 
soluble nucleotides with increase in the DNA hydrolysis 
by S-j^  nuclease with increasing dose of the steroid upto 
certain range (Table 1, Fig.5). Thus steroid transforms 
DNA into an effective substrate for S^ nuclease and 
suggests a destabilization of its secondary structure 
and/or generation of ssbs. However, at higher doses, a 
reduced level of acid soluble material was obtained 
again supporting for the presence of an appreciable 
number of interstrand crosslinks. The possibility of S-j^  
nuclease enzyme getting inactivated by the unbound 
steroid was ruled out by dialysing the reaction mixture 
before subjecting to S^ nuclease reaction. The same 
possibility was also ruled out by another method in 
which S-j^  nuclease was first directly exposed to the 
steroid (100 wM) for 2h at 48 °C and then treated with 
the denatured DNA for 2h at 37°C. The percent hydrolys-
is of the treated DNA was almost the same (99%) as that 
of the control denatured DNA (100%) suggesting the 
complete activity of the enzyme. These results may be 
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considered in support of the thermal melting profile 
pattern as the initial reaction of steroid with DNA 
leads to the formation of local opening alongwith ssbs 
giving rise to a higher rate of hydrolysis by S-^ nuclea-
se while the introduction of an appreciable number of 
crosslinks would obviously reduce the S-^ induced hydro-
lysis. The destabilization of secondary structure of 
native DNA with strand breaks at low doses but the 
appearance of interstrand crosslinks at high doses of 
wethylglyoxal have also been reported (Rahman et ai., 
1990). 
Further studies showed that the steroid, at 
higher doses, itself brought about significant amount of 
DNA degradation (Table 2, Fig.S^). 
We further asked the question as to whether 
DNA destabilization brought about by the steroid 
treatment might involve the base modification. The DEAE 
Sephadex A-50 chromatography conducted for that purpose 
indicated the modification in the pyrimidine bases with 
the higher susceptibility toward thymine (Fig. 4). This 
is in support of our previous result obtained by means 
of Ames test (Chapter III) in which the transition 
mutants, TA102 and TA104, containing the AT hot spots 
were found to be the most responsive strains towards the 
test steroids. 
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Moreover, even under in vitro conditions, the 
steroid in the presence of copper ions could lead to the 
generation of oxygen radical species to degrade sugar 
deoxyribose as well as DNA (data not shown) . Our 
results obtained by means of Ames test (Chapter V) also 
support for the generation of oxygen radical species 
from the test steroid. Moreover, such type of 
deoxyribose and DNA degradation has been reported for 
the antibiotic ^rifamycin' (Quinlan and Gutteridge, 
1987). 
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treated DNA. 
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Table 1 S-^ nuclease hydrolysis of steroid I treated 
calf thymus DNA 
Denatured DNA 
Native DNA 
DNA+solvent 
(as control) 
DNA+steroid 
(dose of steroic 
50 
100 
150 
250 
350 
450 
500 
DNA 
a JUM) 
acid s( 
nucle( 
590 
130 
138 
* 
155 
205 
219 
375 
235 
213 
143 
nuclease hvdro] 
3luble 
jtides 
% DNA 
hydro-
lysed 
100 
22.03 
24.22 
29.10 
36.96 
39.22 
60.97 
41.22 
37.20 
25.20 
Lysis 
% DNA 
hydrolysis 
after subtr-
action from 
control 
-
-
-
4.88 
12.74 
15.00 
36.15 
17.00 
12.98 
0.80 
* (100 uM of steroid = 5.36 jug) 
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Table 2 Degradation of calf thymus DNA treated with 
steroid I (in the absence of S-^ nuclease) 
Denatured DNA 
DNA+solvent 
(as control) 
ug acid 
soluble 
DNA 
nucleo-
tides 
476 
10 
% DNA 
degra-
ded 
100 
2,63 
% DNA degraded 
after subtrac-
tion from 
control 
-
DNA+steroid 
(dose of steroid uM) 
50 
100 
150 
250 
500 
7 
6 
7 
15 
251 
2.149 
2.01 
2.1 
3.88 
53.3U 
0.0 
0.0 
0.0 
1.25 
50.60 
* (100 JJK of steroid == 5.36 iig) 
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Table 3 . Alkaline unwinding assay of steroid I treated calf 
thymus DNA. 
DNA bp/steroid 
molar ratio 
ssDNA dsDNA Total 
DNA 
1 
i 
Fraction 
of duplex 
DNA 
No. of 
unwind 
-ing 
points 
/alka-
line 
unwind 
-ing 
unit 
of DNA 
No. of 
strand 
breaks 
/unit 
DNA 
No steroid 
1:0.25 
1:0.5 
1:1 
1:3 
44.00 146.10 190.13 0.774 
85.05 106.80 191.85 0.55b 2.29 1.29 
87.3 101.85 189.15 0.538 2.41 1.41 
114.15 65.55 179.70 0.364 3.94 2.94 
117.90 63.85 181.75 0.353 4.06 3.06 
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The Salmonella test was first of a:.l used and 
recognized as an appropriate carcinogenicity testing 
system in the study of 300 chemicals most of which were 
known carcinogens (McCann et al., 1975; McCann and Ames, 
1976, 1977) and has since been established for the eval-
uation of the risk of environmental chemicals (Ames, 
1984) . Although the validity of the test has been 
questioned in terms of the actual carcinogenic behaviour 
of the test compound, yet a marked correlation was 
obtained with several mutagenic compounds tested by the 
Salmonella system (McCann et ai., 1975; Flessel et al.. 
1987). Our results indicated a higher degree of mutage-
nicity of the test steroids with GC > AT transition 
mutants, TA102 and TA104 (Levin et al.. , 1982b;' compared 
with those having GC base pairs at the -rjrr.tical site of 
mutation suggesting that the test steroids 
preferentially act upon AT base pairs to bring about 
transition mutation (Table 1, Figs. 1-9 of Chapter 
III). It is also noteworthy that even in the absence of 
Sg microsomal fraction, usually all the tester strains 
responded significantly but the addition of microsomal 
fraction further enhanced the mutagenic activity of the 
steroids (Figs. 1, 5, 6, 7 and 8(B) of Chapter III) 
suggesting that the metabolic products of the test 
steroids were even more mutagenic. 
Comparison of closely related structures 
allows the identification of a number of features 
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essential for the mutagenic activity. Comparing 
steroids I and II which differ only at position 3 of the 
steroidal nucleus (Table 3 of Chapter II) , the acetoxy-
derivative was found to be more mutagenic than the 
chloro-substituted aziridine steroid (Figs, 1 and 2 of 
Chapter III). Among the halogen-substituted steroids at 
position 3 (Table 3 of Chapter II) , the chlorine-
substituted parent was found to be relatively more 
mutagenic compared with other two parent steroids. 
This might be due to higher electronegativity of 
chlorine as compared to bromine and iodine, and thus it 
could have enhanced the electrophilic potential of 
sulfur present at the 6th position. 
The parent steroids containing an equitorial 
halogen atom at 3rd position and a reactive thio-moiety 
at the 6th position were further chemically converted 
into the oxygenated thio-derivatives (steroids IV, V, 
VII, IX and X, Table 3 of Chapter II). This resulted 
into further enhancement of mutagenic activity with the 
increase in number of oxygen atoms in the derivatives 
(Figs. 4-8 of Chapter III) thereby indicating the proba-
ble role of oxygen atoms for the enhanced mutagenicity 
of the steroids. 
Our results are consistent with the idea that 
in some cases the electronegative group present at the 
3rd position of the steroidal nucleus somehow enhances 
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the electrophilic nature of susceptible moiety present 
at the 6th position which in turn, upon interaction with 
some nucleophile in the system generates active oxygen 
radical species. Although the presence of electrophilic 
group in the test steroids seems to be desirable in 
certain cases, it was not probably an essential 
requirement for these compounds to become mutagenic. In 
such cases, the bulky groups present at the 3rd and 6th 
positions might create steric hindrance due to which the 
overall structure becomes unstable and the groups get 
cleaved from the parental nucleus. The cleaved groups 
then probably interact with some reactive species in the 
system and generate oxygen radical species. Moreover, 
our results also indicated that the individual 
moieties/groups were not mutagenic per se (Table 5 of 
Chapter V) . Their association with the steroidal 
nucleus seems to be essential for their remarkable 
mutagenicity (Fig.l and Table 2 of Chapter III). 
The tester strain, TA102, has been reported to 
detect a variety of oxidants and other agents as 
mutagens (Levin et al., 1982a). A significant amount of 
inhibition in the mutation frequency of this strain with 
test steroids was found in the presence of hydroxyl and 
oxygen radical scavengers (Tables 1-4 of Chapter V) . 
This supports for the production of H2O2 and active 
oxygen radical species, 'OH and O2 in the test system. 
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The overall reaction might have been possible 
according to the following Haber-Weiss reaction (Haber 
and Weiss, 1934): 
• ^  
H2O2 + O2 > ©2 + "OH + "OH 
• ^  
A possible source of 'OH and O2 radicals and 
H2O2 in case of the test steroids is summarized in Figs. 
1 and 2 (Chapter V). 
The higher decrease in genotoxicity with the 
scavengers observed when these assays were carried out 
in the presence of liver microsomal fraction compared 
with those without (Tables 1-4 of Chapter V) further 
suggests that the Sg dependent reactive species probably 
differed from those formed chemically. 
The results obtained with E.coli and 
Salmonella systems suggest that the test steroids bring 
about the DNA damage and thus the treated cells initiate 
the SOS-repair with the concomitant induction of 
mutation. The Ames tester strains carry the pKMlOl 
plasmid which is believed to enhance the error-prone 
repair process (Levin et al., 1982b; Little et al. . 
1989). The induction of SOS-response by the test 
steroids in our case was supported by the high sensitiv-
ity of recA and lexA mutants of E.coli towards the test 
steroids (Fig.l of Chapter IV). The role of recA"*" and 
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lexA"*" genes in initiating the error-prone repair in 
E.coii is well documented (Walker, 1985). A significant 
amount of induction of prophage in X~lysogen and requi-
rement of the de novo protein biosynthesis for this 
process (Table 1 of Chapter IV) as well as the induction 
of p-galactosidase in the Mud (Ap, lac) fusion strains 
(Fig.2 of Chapter IV) further substantiate our hypothes-
is. The kinetic studies conducted with steroid-treated 
Mud lysogens displayed a similar response as with 
benzo^a' pyrene (Fig. 3 of Chapter IV) . This suggests 
that induction of the operon fusion gene products might 
occur as a result of a common signal that arises from 
both, steroid and benzo^a' pyrene treatments. Such type 
of response was also observed with mitomycin C at low 
dose (Kenyon and Walker, 1980). The in vitro studies 
also favour this postulation since the test steroids at 
higher doses seem to have induced the interstrand cross-
links in the DNA molecule (Chapter VI) which is a well 
known DNA lesion induced by mitomycin C (Lown, 1977; 
Remers, 1979). 
The results presented in Chapter VI demonstra-
te that the test steroid (I) causes a destabilization in 
the secondary structure of DNA with the formation of 
ssbs. This is evident by the increased level of single 
strandedness in duplex DNA as observed by hydroxyapatite 
chromatography , and increased susceptibility to S^ 
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nuclease (Table 1) as well as decrease in melting tempe-
rature (Fig. 2) at low concentrations of the steroid. 
Moreover, an appreciable amount of denaturation (local 
opening) brought about by low dose exposure of steroid 
is also obvious from the first point of the thermal 
transition profile (Fig. 2) . In addition to these 
facts, alkaline unwinding assay also suggested the exis-
tence of single strand breaks in the treated DNA (Table 
3). 
An interesting finding of these results is 
that at higher steroid/DNA bp molar ratio, a greater Tm 
compared with the control was observed (Fig. 2). This 
implied a sort of stabilization in the secondary struct-
ure of DNA. This result is further strengthened by the 
experiment shown in Fig. 3 where exposure of DNA to high 
dose of steroid followed by forced strand separation by 
boiling the DNA resulted in the incomplete denaturation 
as compared to the untreated control. A reduced rate of 
hydrolysis of DNA with S-^ nuclease at higher dose of 
steroid also supports the same idea. As discussed 
above, these observations can be explained by interstra-
nd cross-linking of DNA at relatively higher concentrat-
ions of steroid. 
The plausible explanation can be envisaged in 
view of the modification of pyrimidine bases (Fig. 4) 
which might disrupt the hydrogen bonding between comple-
(A It 
fl» 
a 
B 
A 
& 
01 
9 
a 
o 
H 
(A 
rt 
A 
•1 
0 
H-
a 
I 
H-
3 
a 
c 
o 
A 
a 
o 
> 
me 
In view of the present findings, we propose 
the following scheme (Fig. 1) for the steroid-induced 
mutagenesis as well as its interaction with DNA. The 
steroid treatment to the bacterial cell/calf- thymus DNA/ 
plasmid DNA generates active oxygen radical species. At 
low dose, it damages DNA, both, in vivo as well as in 
vitro. In vivo damage leads to the initiation of SOS 
response and induction of mutagenesis whereas in vitro 
damage leads to the modification of pyrimidine preferen-
tially in the thymine bases, after or prior to local 
opening in DNA, with the possible formation of single 
strand breaks. At higher doses the intensity of DNA 
damage under in vivo conditions, exceeds the tolerable 
limit of the cell presumably due also to severe injury 
to the metabolic machinery which leads to lethality 
whereas under iji vitro conditions the formation of inte-
rstrand cross-links as well as the DNA degradation 
occurs. 
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SUMMARY 
Naturally occurring as well as synthetic 
steroids have been constantly used in various industries 
(Fishbein, 1984). Both the synthetic steroids and 
aziridines have been reported to possess diversified 
types of biological activities including their contrace-
ptive, antitumour, antineoplastic, cytotoxic and antiba-
cterial characters (La Brecque, 1961; Knipling, 1962; 
Borkovec and Woods, 1963; Oboshi et al., 1967; Derner 
and Hans, 1969; Zbigniew, 1988; Henry et al., 1989; 
Nakaaki, 1989). As we anticipate further developments 
in this area of pharmaceutical chemistry, we made use of 
a local collection of such steroids (Shafiullah et al. , 
1983, 1988, 1990) for mutagenicity testing. The 
practical application of this work is to highlight 
putative hazards in the light of the genotoxicity of 
certain other steroids (Allen et ai., 1981; Metzler, 
1984; Heywood, 1986; Sadek and Abdelmeguid, 1986). The 
short-term assay would obviously be the first step 
forward in the direction of minimizing the exposure to 
the potentially toxic steroids, as prevention is always 
better than cure. Moreover, the rigidity of the 
cholestane ring of steroids used in these studies allows 
structure-function analysis of mutagenic functional 
groups without the complications of conformational 
variation in straight chain compounds. 
The significant findings and possible explana-
tions of the steroid-induced mutagenesis as well as its 
interaction with DNA are summarized as under: 
I. Ames Testing of Test Steroids 
1. All the test steroids resultedinthe enhancement in 
the number of his"*" revertant colonies. 
2. The steroids preferentially act on the AT base pair 
transition mutants, TA102 and TA104 compared with 
those having GC hot spots. 
3. All the tester strains responded significantly even 
in the absence of liver microsomal fraction but the 
addition of microsomal fraction further enhanced the 
mutagenic activity of the steroids. 
4. The parent steroids exhibited less mutagenicity 
compared with their oxygenated derivatives. 
5. Among the parent steroids, the chlorine substituted 
derivative was more mutagenic compared with those 
containing the less electronegative halogens. 
6. The mutagenicity of the steroids was further 
enhanced with the increase in the number of oxygen 
atoms in the derivatives. Moreover, the remarkable 
mutagenic response with the TA102 strain also sugge-
sted for the oxidative nature of mutagenic species. 
7. The mutagenicity of the steroids probably involved 
the generation of oxygen radical species in the 
system. 
8. A significant amount of inhibition of the mutation 
frequency of strain TA102 with steroids in the 
presence of catalase, superoxide-dismutase, formate, 
mannitol and thiourea was observed indicating the 
generation of H2O2 and oxygen radical species, O2 
and 'OH in the test system. 
9. A higher decrease in genotoxicity was observed when 
these assays were carried out in the presence of 
liver microsomal fraction suggesting that the Sg 
dependent reactive species differed from those 
formed chemically. 
10. The individual moieties/groups of the steroid were 
not mutagenic per se. Their association with the 
steroidal nucleus made them remarkably mutagenic. 
These findings are clearly indicative of the 
highly mutagenic nature of the test steroids with the 
preferential induction of AT — > GC transition mutation 
brought about by the probable generation of oxygen 
radical species. Moreover, the metabolic products would 
also be mutagenic. 
II. Role of SOS-Repair and Mutagenesis in the 
steroid-induced Injury 
1. The recA and lexA mutants of E.coli were highly 
sensitive towards the test steroids compared with 
their isogenic wild-type strain. 
2. LexA mutant was found to be more sensitive compared 
with the recA mutant. 
3. A fraction of lysogenic population of >v cI857/HB101 
exhibited the induction of lytic cycle during liguid 
holding in nutrient broth at 32 °C even after 3h 
steroid treatment (0.5 ;ag/ml) to lysogen. The 
prophage induction also reguired the de novo protein 
biosynthesis. 
4. The test steroid (I) induced a low but significant 
amount of p- galactosidase in the Mud (Ap, lac) 
lysogen in solid indicator plate. 
5. The kinetic studies further confirmed the p-
galactosidase induction. Moreover, the kinetic 
studies with steroid-treated Mud lysogens displayed 
a response similar to benzo^a' pyrene. The kinetic 
pattern also indicated that steroid-induced injury 
to E. coli is probably similar to that of mitomycin 
C especially at higher doses. 
All the above mentioned findings strongly 
support for the initiation of inducible error-prone SOS-
response within the steroid-treated E.coli cells. 
III.Interaction of Steroid I with DNA :in vitro studies 
1. The test steroid preferentially modifies thymine and 
to a lesser extent to cytosine bases of calf thymus 
DNA. 
2. At low doses of the steroid (i.e. more DNA 
bp/steroid molar ratio) the hydroxyapatite chromato-
graphy exhibited a significant level of single 
strandedness in the treated DNA whereas at high 
doses the single strandedness was not so marked. 
3. The thermal melting profile data indicated a reduced 
Tm upon treatment of DNA with steroid at low dose 
but at high dose an enhanced Tm with respect to the 
control was obtained. In addition, the steroid-
treated DNA at low dose exhibited a significant 
denaturation even after exposure to submelting 
temperature which supports for the presence of local 
openings (bubbles) in the DNA molecule. 
4. At higher steroid/DNA bp molar ratio, a greater Tm 
as compared to the control was obtained. In 
addition, no strand separation of the treated DNA 
even after exposure to 70°C was observed. Moreover, 
exposure of DNA to high dose of steroid followed by 
forced strand separation by boiling the DNA resulted 
in the incomplete denaturation compared with the 
untreated control. 
5. Studies with S^^ nuclease hydrolysis of the treated 
DNA further confirmed the distortion in the seconda-
ry structure of DNA brought about by the test 
steroid. At lower doses of steroid an appreciable 
increase in the production of acid soluble nucleoti-
des with respect to the control was obtained. 
However, a reduced level of acid soluble material 
was observed at higher doses. 
6. Although the steroid-treated DNA became a more 
effective substrate of S-^  nuclease at lower doses 
but at higher doses the steroid itself could also 
degrade the DNA without requiring any nuclease. 
7. Alkaline unwinding assay indicated an increase in 
the number of strand breaks formed per unit of DNA 
at low doses of steroid but at high dose, there was 
no increase in the number of strand breaks. 
In view of these in vitro studies, it is 
evident that at lower concentrations, the steroid prima-
rily causes local opening of the duplex DNA after or 
prior to pyrimidine base modifications with the formati-
on of ssbs but at higher doses, the treated DNA seems to 
have undergone the degradation and interstrand crosslin-
king. 
In view of our findings, we propose the 
following hypothetical mechanism of mutagenic action of 
the test steroids: 
CsKx 
>^0-0-H X-O-OfH 
XVOOH XOO'+'H 
Less probable 
X-D-H 
or 
Intermediates of unknown 
nature including the 
-* formation of X-O-O-H 
(mostly in radical form, 
unstable) 
X-O^O-H 
JHomolytic fission 
XO+JDH] 
More probable 
•OH+'OH HlOj 
XOH 
Y 
Z 
Z+ 
= Reactive species and/or nucleophile (within cell ?) 
= Halogen and/or bulky group (equitorial ?) 
= Substituted group 
= Influence of Y and Z over each other 
= Electrophile 
Encircled 
Steroidal 
structure Highly hydrophobic part of the steroid 
molecule and thus suitable for interaction 
with locally opened duplex DNA as well as 
for slipping between the two strands. 
Fig. 1 . Hypothetical mechanism of mutagenic action of 
test steroids. 
